# Netflix timeline

entity: /record/netflix.md  
id: ent_netflix  


## undated

- undated | fiscal_year_end | 12-31 | valid | [clm_4B2BEA83952D](/claim/clm_4B2BEA83952D.md)
- undated | ticker | NFLX | valid | [clm_5E9486F4DBBF](/claim/clm_5E9486F4DBBF.md)
- undated | listed_on | Nasdaq | valid | [clm_61D288818ABF](/claim/clm_61D288818ABF.md)
- undated | cik | 0001065280 | valid | [clm_7ADF32A58B65](/claim/clm_7ADF32A58B65.md)
- undated | sic_industry | Services-Video Tape Rental (7841) | valid | [clm_B427E8C16241](/claim/clm_B427E8C16241.md)
- undated | state_of_incorporation | DE | valid | [clm_B461F101E927](/claim/clm_B461F101E927.md)
- undated to 2000-04-18 | registrant_name | NETFLIX INC | superseded | [clm_FBF436F11A9B](/claim/clm_FBF436F11A9B.md)
- undated | linkedin | netflixph | unverified | [clm_8BF48FC95F0B](/claim/clm_8BF48FC95F0B.md)
- undated | website | https://netflix.com/ | unverified | [clm_AC1FF4309D25](/claim/clm_AC1FF4309D25.md)
- undated | website | https://www.netflix.com/ | unverified | [clm_CC9D2873CF35](/claim/clm_CC9D2873CF35.md)

## 2000

- 2000-04-18 to 2002-03-06 | registrant_name | NETFLIX COM INC | superseded | [clm_52A31AF5A2CB](/claim/clm_52A31AF5A2CB.md)

## 2006

- 2006-12-31 to 2007-12-31 | total_equity | 413,618,000 United States dollar | superseded | [clm_9DA51633C070](/claim/clm_9DA51633C070.md)
- 2006-12-31 to 2007-12-31 | cash_and_equivalents | 400,430,000 United States dollar | superseded | [clm_F43034B87D24](/claim/clm_F43034B87D24.md)

## 2007

- 2007-12-31 to 2008-12-31 | research_and_development | 70,979,000 United States dollar | superseded | [clm_0F8A011E1B78](/claim/clm_0F8A011E1B78.md)
- 2007-12-31 to 2008-12-31 | net_income | 66,608,000 United States dollar | superseded | [clm_4BEA5724141A](/claim/clm_4BEA5724141A.md)
- 2007-12-31 to 2008-03-31 | cash_and_equivalents | 177,439,000 United States dollar | superseded | [clm_9A2A91B0CC37](/claim/clm_9A2A91B0CC37.md)
- 2007-12-31 to 2008-12-31 | revenue | 1,205,340,000 United States dollar | superseded | [clm_A83717FEC956](/claim/clm_A83717FEC956.md)
- 2007-12-31 to 2008-12-31 | operating_income | 91,773,000 United States dollar | superseded | [clm_AFB3BCE9795F](/claim/clm_AFB3BCE9795F.md)
- 2007-12-31 to 2008-12-31 | total_equity | 429,812,000 United States dollar | superseded | [clm_BD2DD3EB0244](/claim/clm_BD2DD3EB0244.md)

## 2008

- 2008-03-31 to 2008-06-30 | cash_and_equivalents | 168,989,000 United States dollar | superseded | [clm_57F0FF744E55](/claim/clm_57F0FF744E55.md)
- 2008-06-30 to 2008-09-30 | quarterly_net_income | 26,579,000 United States dollar | superseded | [clm_2D9738331EDD](/claim/clm_2D9738331EDD.md)
- 2008-06-30 to 2008-09-30 | quarterly_revenue | 337,614,000 United States dollar | superseded | [clm_6D9CC8A85650](/claim/clm_6D9CC8A85650.md)
- 2008-06-30 to 2008-09-30 | quarterly_operating_income | 34,201,000 United States dollar | superseded | [clm_A020B7B8743F](/claim/clm_A020B7B8743F.md)
- 2008-06-30 to 2008-09-30 | cash_and_equivalents | 144,289,000 United States dollar | superseded | [clm_C62D4528CFB6](/claim/clm_C62D4528CFB6.md)
- 2008-06-30 to 2008-09-30 | quarterly_research_and_development | 22,186,000 United States dollar | superseded | [clm_FCD8E0DC11AA](/claim/clm_FCD8E0DC11AA.md)
- 2008-09-30 to 2009-03-31 | quarterly_research_and_development | 23,368,000 United States dollar | superseded | [clm_0108362B5DC2](/claim/clm_0108362B5DC2.md)
- 2008-09-30 to 2009-03-31 | quarterly_revenue | 341,269,000 United States dollar | superseded | [clm_0A579AF8CFB2](/claim/clm_0A579AF8CFB2.md)
- 2008-09-30 to 2008-12-31 | cash_and_equivalents | 111,524,000 United States dollar | superseded | [clm_25E2DF22A81C](/claim/clm_25E2DF22A81C.md)
- 2008-09-30 to 2009-03-31 | quarterly_net_income | 20,371,000 United States dollar | superseded | [clm_2B92A85C34DA](/claim/clm_2B92A85C34DA.md)
- 2008-09-30 to 2009-03-31 | quarterly_operating_income | 34,074,000 United States dollar | superseded | [clm_3ACD74140EEA](/claim/clm_3ACD74140EEA.md)
- 2008-10-03 | x_username | netflix | unverified | [clm_EB67550ADD27](/claim/clm_EB67550ADD27.md)
- 2008-12-31 to 2009-03-31 | cash_and_equivalents | 139,881,000 United States dollar | superseded | [clm_2AC6A986AB7A](/claim/clm_2AC6A986AB7A.md)
- 2008-12-31 to 2009-12-31 | revenue | 1,364,661,000 United States dollar | superseded | [clm_3E81B08F892E](/claim/clm_3E81B08F892E.md)
- 2008-12-31 to 2009-06-30 | total_equity | 347,155,000 United States dollar | superseded | [clm_4159AC410FD4](/claim/clm_4159AC410FD4.md)
- 2008-12-31 to 2009-12-31 | operating_income | 121,506,000 United States dollar | superseded | [clm_887AD04E5DBD](/claim/clm_887AD04E5DBD.md)
- 2008-12-31 to 2009-12-31 | net_income | 83,026,000 United States dollar | superseded | [clm_9B7EDF0FB5F0](/claim/clm_9B7EDF0FB5F0.md)
- 2008-12-31 to 2009-06-30 | total_assets | 615,424,000 United States dollar | superseded | [clm_BEEEB558877F](/claim/clm_BEEEB558877F.md)
- 2008-12-31 to 2009-12-31 | research_and_development | 89,873,000 United States dollar | superseded | [clm_DE849B45E955](/claim/clm_DE849B45E955.md)

## 2009

- 2009-02-21 | x_username | Netflixhelps | unverified | [clm_FD98B86BF690](/claim/clm_FD98B86BF690.md)
- 2009-03-31 to 2009-06-30 | cash_and_equivalents | 115,131,000 United States dollar | superseded | [clm_034F6100D0FD](/claim/clm_034F6100D0FD.md)
- 2009-03-31 to 2009-06-30 | quarterly_operating_income | 36,471,000 United States dollar | superseded | [clm_1AAF78CE0B25](/claim/clm_1AAF78CE0B25.md)
- 2009-03-31 to 2009-06-30 | quarterly_net_income | 22,363,000 United States dollar | superseded | [clm_446499F660F6](/claim/clm_446499F660F6.md)
- 2009-03-31 to 2009-06-30 | quarterly_research_and_development | 24,200,000 United States dollar | superseded | [clm_8193E16A1553](/claim/clm_8193E16A1553.md)
- 2009-03-31 to 2009-06-30 | quarterly_revenue | 394,098,000 United States dollar | superseded | [clm_EDD68703C804](/claim/clm_EDD68703C804.md)
- 2009-06-30 to 2009-09-30 | quarterly_operating_income | 52,782,000 United States dollar | superseded | [clm_32EBD9E1E7BA](/claim/clm_32EBD9E1E7BA.md)
- 2009-06-30 to 2009-09-30 | cash_and_equivalents | 87,471,000 United States dollar | superseded | [clm_3CF67A58E4C3](/claim/clm_3CF67A58E4C3.md)
- 2009-06-30 to 2009-09-30 | shares_outstanding | 57,415,726 shares | superseded | [clm_4BA8ABD5CDC6](/claim/clm_4BA8ABD5CDC6.md)
- 2009-06-30 to 2009-09-30 | quarterly_research_and_development | 27,119,000 United States dollar | superseded | [clm_7C39A6CA851A](/claim/clm_7C39A6CA851A.md)
- 2009-06-30 to 2009-09-30 | quarterly_revenue | 408,509,000 United States dollar | superseded | [clm_911F3FD7159C](/claim/clm_911F3FD7159C.md)
- 2009-06-30 to 2009-09-30 | total_equity | 324,371,000 United States dollar | superseded | [clm_C37FA5DAF5A4](/claim/clm_C37FA5DAF5A4.md)
- 2009-06-30 to 2009-09-30 | total_assets | 591,993,000 United States dollar | superseded | [clm_C4685F9276A8](/claim/clm_C4685F9276A8.md)
- 2009-06-30 to 2009-09-30 | quarterly_net_income | 32,443,000 United States dollar | superseded | [clm_ECB0358E4B49](/claim/clm_ECB0358E4B49.md)
- 2009-09-30 to 2010-01-31 | shares_outstanding | 54,642,694 shares | superseded | [clm_0D0153AB3431](/claim/clm_0D0153AB3431.md)
- 2009-09-30 to 2010-03-31 | quarterly_operating_income | 49,337,000 United States dollar | superseded | [clm_2D7E52F0D728](/claim/clm_2D7E52F0D728.md)
- 2009-09-30 to 2009-12-31 | total_equity | 232,202,000 United States dollar | superseded | [clm_43E1EE2C65B7](/claim/clm_43E1EE2C65B7.md)
- 2009-09-30 to 2010-03-31 | quarterly_research_and_development | 30,014,000 United States dollar | superseded | [clm_55C596E737B5](/claim/clm_55C596E737B5.md)
- 2009-09-30 to 2009-12-31 | cash_and_equivalents | 55,717,000 United States dollar | superseded | [clm_67E2C77FCB39](/claim/clm_67E2C77FCB39.md)
- 2009-09-30 to 2009-12-31 | total_assets | 492,131,000 United States dollar | superseded | [clm_895B9797871C](/claim/clm_895B9797871C.md)
- 2009-09-30 to 2010-03-31 | quarterly_revenue | 423,120,000 United States dollar | superseded | [clm_EAA4AA7258A3](/claim/clm_EAA4AA7258A3.md)
- 2009-09-30 to 2010-03-31 | quarterly_net_income | 30,141,000 United States dollar | superseded | [clm_EB2E8D842562](/claim/clm_EB2E8D842562.md)
- 2009-12-31 to 2010-03-31 | total_equity | 199,143,000 United States dollar | superseded | [clm_0BE6F238BA18](/claim/clm_0BE6F238BA18.md)
- 2009-12-31 to 2010-12-31 | net_income | 115,860,000 United States dollar | superseded | [clm_1E107FB8EB60](/claim/clm_1E107FB8EB60.md)
- 2009-12-31 to 2010-12-31 | revenue | 1,670,269,000 United States dollar | superseded | [clm_56E3CE47E4CF](/claim/clm_56E3CE47E4CF.md)
- 2009-12-31 to 2010-12-31 | operating_income | 191,939,000 United States dollar | superseded | [clm_8E5A1797CE30](/claim/clm_8E5A1797CE30.md)
- 2009-12-31 to 2010-12-31 | research_and_development | 114,542,000 United States dollar | superseded | [clm_B94A8DDD714F](/claim/clm_B94A8DDD714F.md)
- 2009-12-31 to 2010-03-31 | total_assets | 679,734,000 United States dollar | superseded | [clm_C9566233BFD3](/claim/clm_C9566233BFD3.md)
- 2009-12-31 to 2010-03-31 | cash_and_equivalents | 134,224,000 United States dollar | superseded | [clm_E5772FC7F0DE](/claim/clm_E5772FC7F0DE.md)

## 2010

- 2010-01-31 to 2010-03-31 | shares_outstanding | 53,533,265 shares | superseded | [clm_EF7C8E89CC2D](/claim/clm_EF7C8E89CC2D.md)
- 2010-03-31 to 2010-06-30 | total_assets | 648,293,000 United States dollar | superseded | [clm_180FD9BAA042](/claim/clm_180FD9BAA042.md)
- 2010-03-31 to 2010-06-30 | quarterly_research_and_development | 37,399,000 United States dollar | superseded | [clm_21450B5E510E](/claim/clm_21450B5E510E.md)
- 2010-03-31 to 2010-06-30 | total_equity | 146,735,000 United States dollar | superseded | [clm_4F3BB8D2A7F7](/claim/clm_4F3BB8D2A7F7.md)
- 2010-03-31 to 2010-06-30 | quarterly_operating_income | 58,345,000 United States dollar | superseded | [clm_53BA9683D30D](/claim/clm_53BA9683D30D.md)
- 2010-03-31 to 2010-06-30 | quarterly_revenue | 493,665,000 United States dollar | superseded | [clm_66A920E79C7A](/claim/clm_66A920E79C7A.md)
- 2010-03-31 to 2010-06-30 | cash_and_equivalents | 79,861,000 United States dollar | superseded | [clm_8E4DF566FAC2](/claim/clm_8E4DF566FAC2.md)
- 2010-03-31 to 2010-06-30 | shares_outstanding | 52,261,855 shares | superseded | [clm_F02913FE89BC](/claim/clm_F02913FE89BC.md)
- 2010-03-31 to 2010-06-30 | quarterly_net_income | 32,272,000 United States dollar | superseded | [clm_FF991589067F](/claim/clm_FF991589067F.md)
- 2010-06-30 to 2010-09-30 | quarterly_revenue | 519,819,000 United States dollar | superseded | [clm_2812CC7B5F3A](/claim/clm_2812CC7B5F3A.md)
- 2010-06-30 to 2010-09-30 | total_assets | 693,972,000 United States dollar | superseded | [clm_53C226409B2B](/claim/clm_53C226409B2B.md)
- 2010-06-30 to 2010-09-30 | quarterly_operating_income | 77,342,000 United States dollar | superseded | [clm_67ADA9765885](/claim/clm_67ADA9765885.md)
- 2010-06-30 to 2010-09-30 | quarterly_research_and_development | 37,863,000 United States dollar | superseded | [clm_AFF1FBC15924](/claim/clm_AFF1FBC15924.md)
- 2010-06-30 to 2010-09-30 | shares_outstanding | 52,358,171 shares | superseded | [clm_B1ED1B56528D](/claim/clm_B1ED1B56528D.md)
- 2010-06-30 to 2010-09-30 | total_equity | 176,640,000 United States dollar | superseded | [clm_E2CA6405692E](/claim/clm_E2CA6405692E.md)
- 2010-06-30 to 2010-09-30 | quarterly_net_income | 43,519,000 United States dollar | superseded | [clm_E8BDE19D8EB2](/claim/clm_E8BDE19D8EB2.md)
- 2010-06-30 to 2010-09-30 | cash_and_equivalents | 107,327,000 United States dollar | superseded | [clm_F7FCB4F72148](/claim/clm_F7FCB4F72148.md)
- 2010-09-30 to 2010-12-31 | total_equity | 191,975,000 United States dollar | superseded | [clm_0C3BA9AF4A39](/claim/clm_0C3BA9AF4A39.md)
- 2010-09-30 to 2010-12-31 | total_assets | 770,283,000 United States dollar | superseded | [clm_30E4BCB8EF45](/claim/clm_30E4BCB8EF45.md)
- 2010-09-30 | x_username | Netflix_CA | unverified | [clm_372FC596F843](/claim/clm_372FC596F843.md)
- 2010-09-30 to 2011-03-31 | quarterly_net_income | 37,967,000 United States dollar | superseded | [clm_468180D35493](/claim/clm_468180D35493.md)
- 2010-09-30 to 2011-01-31 | shares_outstanding | 52,257,495 shares | superseded | [clm_5363485CB394](/claim/clm_5363485CB394.md)
- 2010-09-30 to 2011-03-31 | quarterly_revenue | 553,219,000 United States dollar | superseded | [clm_55DA9888288F](/claim/clm_55DA9888288F.md)
- 2010-09-30 to 2011-03-31 | quarterly_operating_income | 69,501,000 United States dollar | superseded | [clm_81F10E419D17](/claim/clm_81F10E419D17.md)
- 2010-09-30 to 2011-03-31 | quarterly_research_and_development | 42,108,000 United States dollar | superseded | [clm_C86E444D777A](/claim/clm_C86E444D777A.md)
- 2010-09-30 to 2010-12-31 | cash_and_equivalents | 113,108,000 United States dollar | superseded | [clm_EA3F56C1310B](/claim/clm_EA3F56C1310B.md)
- 2010-12-27 | x_username | NetflixUK | unverified | [clm_14C0934F0E0D](/claim/clm_14C0934F0E0D.md)
- 2010-12-28 | x_username | NetflixBrasil | unverified | [clm_4AA706F842EC](/claim/clm_4AA706F842EC.md)
- 2010-12-28 | x_username | NetflixLAT | unverified | [clm_E59C6A629246](/claim/clm_E59C6A629246.md)
- 2010-12-31 to 2011-03-31 | total_assets | 982,067,000 United States dollar | superseded | [clm_175AF236E52E](/claim/clm_175AF236E52E.md)
- 2010-12-31 to 2011-03-31 | total_equity | 290,164,000 United States dollar | superseded | [clm_4C76C44CF68D](/claim/clm_4C76C44CF68D.md)
- 2010-12-31 to 2011-12-31 | net_income | 160,853,000 United States dollar | superseded | [clm_4EA85C9E93C6](/claim/clm_4EA85C9E93C6.md)
- 2010-12-31 to 2011-12-31 | operating_income | 283,641,000 United States dollar | superseded | [clm_727708A4CD7A](/claim/clm_727708A4CD7A.md)
- 2010-12-31 to 2011-12-31 | research_and_development | 163,329,000 United States dollar | superseded | [clm_8B0E74096CB0](/claim/clm_8B0E74096CB0.md)
- 2010-12-31 to 2011-03-31 | cash_and_equivalents | 194,499,000 United States dollar | superseded | [clm_B2520BACD4DB](/claim/clm_B2520BACD4DB.md)
- 2010-12-31 to 2011-12-31 | revenue | 2,162,625,000 United States dollar | superseded | [clm_E07608745EAE](/claim/clm_E07608745EAE.md)

## 2011

- 2011-01-31 to 2011-03-31 | shares_outstanding | 52,890,638 shares | superseded | [clm_1DB382B9495B](/claim/clm_1DB382B9495B.md)
- 2011-03-31 to 2011-06-30 | cash_and_equivalents | 150,419,000 United States dollar | superseded | [clm_036784376E67](/claim/clm_036784376E67.md)
- 2011-03-31 to 2011-06-30 | total_equity | 275,722,000 United States dollar | superseded | [clm_3B3AF9CCA10E](/claim/clm_3B3AF9CCA10E.md)
- 2011-03-31 to 2011-06-30 | quarterly_operating_income | 102,240,000 United States dollar | superseded | [clm_4AC2FBAD3FA0](/claim/clm_4AC2FBAD3FA0.md)
- 2011-03-31 to 2011-06-30 | total_assets | 1,090,188,000 United States dollar | superseded | [clm_4B83F3D0880E](/claim/clm_4B83F3D0880E.md)
- 2011-03-31 to 2011-06-30 | shares_outstanding | 52,519,159 shares | superseded | [clm_71060138AEFB](/claim/clm_71060138AEFB.md)
- 2011-03-31 to 2011-06-30 | quarterly_net_income | 60,233,000 United States dollar | superseded | [clm_741D537D8862](/claim/clm_741D537D8862.md)
- 2011-03-31 to 2011-06-30 | quarterly_research_and_development | 50,905,000 United States dollar | superseded | [clm_75552F65C35C](/claim/clm_75552F65C35C.md)
- 2011-03-31 to 2011-06-30 | quarterly_revenue | 718,553,000 United States dollar | superseded | [clm_AA0B204B8F2C](/claim/clm_AA0B204B8F2C.md)
- 2011-06-30 to 2011-09-30 | quarterly_operating_income | 115,114,000 United States dollar | superseded | [clm_01A85A48966E](/claim/clm_01A85A48966E.md)
- 2011-06-30 to 2011-09-30 | total_assets | 1,570,693,000 United States dollar | superseded | [clm_14C22B2AEF78](/claim/clm_14C22B2AEF78.md)
- 2011-06-30 to 2011-09-30 | shares_outstanding | 52,536,246 shares | superseded | [clm_3647D5DE06A7](/claim/clm_3647D5DE06A7.md)
- 2011-06-30 to 2011-09-30 | cash_and_equivalents | 175,207,000 United States dollar | superseded | [clm_37ADB25B4FF6](/claim/clm_37ADB25B4FF6.md)
- 2011-06-30 to 2011-09-30 | quarterly_revenue | 788,610,000 United States dollar | superseded | [clm_3D016E501881](/claim/clm_3D016E501881.md)
- 2011-06-30 to 2011-09-30 | quarterly_net_income | 68,214,000 United States dollar | superseded | [clm_451E400918B9](/claim/clm_451E400918B9.md)
- 2011-06-30 to 2011-09-30 | total_equity | 334,034,000 United States dollar | superseded | [clm_BE0BE018E6DE](/claim/clm_BE0BE018E6DE.md)
- 2011-06-30 to 2011-09-30 | quarterly_research_and_development | 57,865,000 United States dollar | superseded | [clm_CD3A26320643](/claim/clm_CD3A26320643.md)
- 2011-09-30 to 2012-01-31 | shares_outstanding | 52,504,091 shares | superseded | [clm_1AD79F1C8469](/claim/clm_1AD79F1C8469.md)
- 2011-09-30 to 2011-12-31 | total_assets | 1,961,558,000 United States dollar | superseded | [clm_4D40C1591F05](/claim/clm_4D40C1591F05.md)
- 2011-09-30 to 2012-03-31 | quarterly_net_income | 62,460,000 United States dollar | superseded | [clm_4F331F1410E4](/claim/clm_4F331F1410E4.md)
- 2011-09-30 to 2012-03-31 | quarterly_operating_income | 96,842,000 United States dollar | superseded | [clm_6A71B2274348](/claim/clm_6A71B2274348.md)
- 2011-09-30 to 2011-12-31 | cash_and_equivalents | 159,199,000 United States dollar | superseded | [clm_93BBF0C6252F](/claim/clm_93BBF0C6252F.md)
- 2011-09-30 to 2011-12-31 | total_equity | 388,352,000 United States dollar | superseded | [clm_C1B25A0EA068](/claim/clm_C1B25A0EA068.md)
- 2011-09-30 to 2012-03-31 | quarterly_research_and_development | 69,480,000 United States dollar | superseded | [clm_E25A2A7F5D6D](/claim/clm_E25A2A7F5D6D.md)
- 2011-09-30 to 2012-03-31 | quarterly_revenue | 821,839,000 United States dollar | superseded | [clm_F59119977D0E](/claim/clm_F59119977D0E.md)
- 2011-12-31 to 2012-12-31 | revenue | 3,204,577,000 United States dollar | superseded | [clm_92A2D9E3E7D3](/claim/clm_92A2D9E3E7D3.md)
- 2011-12-31 to 2012-12-31 | net_income | 226,126,000 United States dollar | superseded | [clm_97647B46BC85](/claim/clm_97647B46BC85.md)
- 2011-12-31 to 2012-12-31 | operating_income | 376,068,000 United States dollar | superseded | [clm_9A00393FF117](/claim/clm_9A00393FF117.md)
- 2011-12-31 to 2012-03-31 | total_equity | 642,810,000 United States dollar | superseded | [clm_9ED7F062338E](/claim/clm_9ED7F062338E.md)
- 2011-12-31 to 2012-12-31 | research_and_development | 259,033,000 United States dollar | superseded | [clm_E306F5C40F55](/claim/clm_E306F5C40F55.md)
- 2011-12-31 to 2012-03-31 | cash_and_equivalents | 508,053,000 United States dollar | superseded | [clm_F4AFD22BBC33](/claim/clm_F4AFD22BBC33.md)
- 2011-12-31 to 2012-03-31 | total_assets | 3,069,196,000 United States dollar | superseded | [clm_F68CFCCDF2A4](/claim/clm_F68CFCCDF2A4.md)

## 2012

- 2012-01-31 to 2012-03-31 | shares_outstanding | 55,418,632 shares | superseded | [clm_7E99C6A1231C](/claim/clm_7E99C6A1231C.md)
- 2012-03-31 to 2012-06-30 | shares_outstanding | 55,515,631 shares | superseded | [clm_15292F75D900](/claim/clm_15292F75D900.md)
- 2012-03-31 to 2012-06-30 | quarterly_operating_income | -1,935,000 United States dollar | superseded | [clm_4DB997F59E30](/claim/clm_4DB997F59E30.md)
- 2012-03-31 to 2012-06-30 | total_equity | 663,402,000 United States dollar | superseded | [clm_5AAE2CB211C0](/claim/clm_5AAE2CB211C0.md)
- 2012-03-31 to 2012-06-30 | cash_and_equivalents | 395,992,000 United States dollar | superseded | [clm_79AE7F594E8B](/claim/clm_79AE7F594E8B.md)
- 2012-03-31 to 2012-06-30 | quarterly_research_and_development | 82,801,000 United States dollar | superseded | [clm_8D0F86CC6AFA](/claim/clm_8D0F86CC6AFA.md)
- 2012-03-31 to 2012-06-30 | total_assets | 3,480,459,000 United States dollar | superseded | [clm_99C7E8017BBA](/claim/clm_99C7E8017BBA.md)
- 2012-03-31 to 2012-06-30 | quarterly_net_income | -4,584,000 United States dollar | superseded | [clm_9E0765AFF434](/claim/clm_9E0765AFF434.md)
- 2012-03-31 to 2012-06-30 | quarterly_revenue | 869,791,000 United States dollar | superseded | [clm_DB5074586BA0](/claim/clm_DB5074586BA0.md)
- 2012-06-30 to 2012-09-30 | quarterly_operating_income | 16,154,000 United States dollar | superseded | [clm_0C978C744869](/claim/clm_0C978C744869.md)
- 2012-06-30 to 2012-09-30 | quarterly_revenue | 889,163,000 United States dollar | superseded | [clm_50200412D561](/claim/clm_50200412D561.md)
- 2012-06-30 to 2012-09-30 | shares_outstanding | 55,534,266 shares | superseded | [clm_5BC13A3164EE](/claim/clm_5BC13A3164EE.md)
- 2012-06-30 to 2012-09-30 | quarterly_net_income | 6,164,000 United States dollar | superseded | [clm_CA38297C94DC](/claim/clm_CA38297C94DC.md)
- 2012-06-30 to 2012-09-30 | total_equity | 688,226,000 United States dollar | superseded | [clm_DC20060635D0](/claim/clm_DC20060635D0.md)
- 2012-06-30 to 2012-09-30 | quarterly_research_and_development | 81,547,000 United States dollar | superseded | [clm_E76F08D190E4](/claim/clm_E76F08D190E4.md)
- 2012-06-30 to 2012-09-30 | cash_and_equivalents | 402,251,000 United States dollar | superseded | [clm_EAD9037ACCE5](/claim/clm_EAD9037ACCE5.md)
- 2012-06-30 to 2012-09-30 | total_assets | 3,478,290,000 United States dollar | superseded | [clm_FD2E9FB0188E](/claim/clm_FD2E9FB0188E.md)
- 2012-08-14 | x_username | NetflixNordic | unverified | [clm_B77B4FB3977C](/claim/clm_B77B4FB3977C.md)
- 2012-09-30 to 2013-03-31 | quarterly_operating_income | 16,135,000 United States dollar | superseded | [clm_301FC586D713](/claim/clm_301FC586D713.md)
- 2012-09-30 to 2013-03-31 | quarterly_revenue | 905,089,000 United States dollar | superseded | [clm_43EED1FC26D8](/claim/clm_43EED1FC26D8.md)
- 2012-09-30 to 2012-12-31 | total_assets | 3,808,833,000 United States dollar | superseded | [clm_4841FF0B3D27](/claim/clm_4841FF0B3D27.md)
- 2012-09-30 to 2013-03-31 | quarterly_net_income | 7,675,000 United States dollar | superseded | [clm_68AC339B4678](/claim/clm_68AC339B4678.md)
- 2012-09-30 to 2012-12-31 | total_equity | 716,840,000 United States dollar | superseded | [clm_6F3FE709024F](/claim/clm_6F3FE709024F.md)
- 2012-09-30 to 2012-12-31 | cash_and_equivalents | 370,298,000 United States dollar | superseded | [clm_75BC7BD506D4](/claim/clm_75BC7BD506D4.md)
- 2012-09-30 to 2013-01-31 | shares_outstanding | 55,545,531 shares | superseded | [clm_7AF57F4F79B6](/claim/clm_7AF57F4F79B6.md)
- 2012-09-30 to 2013-03-31 | quarterly_research_and_development | 82,521,000 United States dollar | superseded | [clm_EB4F5B9FA8E5](/claim/clm_EB4F5B9FA8E5.md)
- 2012-12-31 to 2013-03-31 | total_equity | 744,673,000 United States dollar | superseded | [clm_23CAEEA44EA4](/claim/clm_23CAEEA44EA4.md)
- 2012-12-31 to 2013-03-31 | total_assets | 3,967,890,000 United States dollar | superseded | [clm_41F3B5395F96](/claim/clm_41F3B5395F96.md)
- 2012-12-31 to 2013-12-31 | operating_income | 49,992,000 United States dollar | superseded | [clm_4508D01B7D91](/claim/clm_4508D01B7D91.md)
- 2012-12-31 to 2013-12-31 | net_income | 17,152,000 United States dollar | superseded | [clm_473362D4ADFF](/claim/clm_473362D4ADFF.md)
- 2012-12-31 to 2013-03-31 | cash_and_equivalents | 290,291,000 United States dollar | superseded | [clm_7BA4B805B741](/claim/clm_7BA4B805B741.md)
- 2012-12-31 to 2013-12-31 | revenue | 3,609,282,000 United States dollar | superseded | [clm_8E650553D809](/claim/clm_8E650553D809.md)
- 2012-12-31 to 2013-12-31 | research_and_development | 329,008,000 United States dollar | superseded | [clm_CA4AE5349DBB](/claim/clm_CA4AE5349DBB.md)

## 2013

- 2013-01-31 to 2013-03-31 | shares_outstanding | 55,993,477 shares | superseded | [clm_735D3E7F5531](/claim/clm_735D3E7F5531.md)
- 2013-03-31 to 2013-06-30 | total_assets | 4,363,289,000 United States dollar | superseded | [clm_03CB7E79AD36](/claim/clm_03CB7E79AD36.md)
- 2013-03-31 to 2013-06-30 | shares_outstanding | 56,143,986 shares | superseded | [clm_047614C451D7](/claim/clm_047614C451D7.md)
- 2013-03-31 to 2013-06-30 | quarterly_net_income | 2,689,000 United States dollar | superseded | [clm_0777488898D3](/claim/clm_0777488898D3.md)
- 2013-03-31 to 2013-06-30 | quarterly_research_and_development | 91,975,000 United States dollar | superseded | [clm_433374DDE6D5](/claim/clm_433374DDE6D5.md)
- 2013-03-31 to 2013-06-30 | quarterly_revenue | 1,023,961,000 United States dollar | superseded | [clm_60397BF25A84](/claim/clm_60397BF25A84.md)
- 2013-03-31 to 2013-06-30 | quarterly_operating_income | 31,822,000 United States dollar | superseded | [clm_701196C144DD](/claim/clm_701196C144DD.md)
- 2013-03-31 to 2013-06-30 | cash_and_equivalents | 418,051,000 United States dollar | superseded | [clm_750CD5E262A6](/claim/clm_750CD5E262A6.md)
- 2013-03-31 to 2013-06-30 | total_equity | 812,919,000 United States dollar | superseded | [clm_BE843DAB1D58](/claim/clm_BE843DAB1D58.md)
- 2013-06-30 to 2013-09-30 | quarterly_research_and_development | 93,126,000 United States dollar | superseded | [clm_1B46ACA67533](/claim/clm_1B46ACA67533.md)
- 2013-06-30 to 2013-09-30 | total_equity | 1,105,622,000 United States dollar | superseded | [clm_494D7C49C7B7](/claim/clm_494D7C49C7B7.md)
- 2013-06-30 to 2013-09-30 | quarterly_revenue | 1,069,372,000 United States dollar | superseded | [clm_57DE63C285D1](/claim/clm_57DE63C285D1.md)
- 2013-06-30 to 2013-09-30 | shares_outstanding | 58,922,493 shares | superseded | [clm_771F55D9C499](/claim/clm_771F55D9C499.md)
- 2013-06-30 to 2013-09-30 | quarterly_net_income | 29,471,000 United States dollar | superseded | [clm_8197538ABF17](/claim/clm_8197538ABF17.md)
- 2013-06-30 to 2013-09-30 | total_assets | 4,480,751,000 United States dollar | superseded | [clm_8C7302C078C4](/claim/clm_8C7302C078C4.md)
- 2013-06-30 to 2013-09-30 | cash_and_equivalents | 370,678,000 United States dollar | superseded | [clm_9E8FE1216B1A](/claim/clm_9E8FE1216B1A.md)
- 2013-06-30 to 2013-09-30 | quarterly_operating_income | 57,117,000 United States dollar | superseded | [clm_C6E2785B0CF2](/claim/clm_C6E2785B0CF2.md)
- 2013-09-30 to 2014-03-31 | quarterly_operating_income | 57,120,000 United States dollar | superseded | [clm_2C7CB4AE2878](/claim/clm_2C7CB4AE2878.md)
- 2013-09-30 to 2014-01-30 | shares_outstanding | 59,257,798 shares | superseded | [clm_4146E51553B8](/claim/clm_4146E51553B8.md)
- 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 95,540,000 United States dollar | superseded | [clm_644F7FE7F467](/claim/clm_644F7FE7F467.md)
- 2013-09-30 to 2014-03-31 | quarterly_revenue | 1,105,999,000 United States dollar | superseded | [clm_80510136342C](/claim/clm_80510136342C.md)
- 2013-09-30 to 2013-12-31 | total_equity | 1,204,370,000 United States dollar | superseded | [clm_99171E884044](/claim/clm_99171E884044.md)
- 2013-09-30 to 2013-12-31 | total_assets | 4,901,325,000 United States dollar | superseded | [clm_9C77B520B4D8](/claim/clm_9C77B520B4D8.md)
- 2013-09-30 to 2013-12-31 | cash_and_equivalents | 439,056,000 United States dollar | superseded | [clm_A3B611F39EE2](/claim/clm_A3B611F39EE2.md)
- 2013-09-30 to 2014-03-31 | quarterly_net_income | 31,822,000 United States dollar | superseded | [clm_B647EEC276E9](/claim/clm_B647EEC276E9.md)
- 2013-12-31 to 2014-03-31 | total_assets | 5,412,563,000 United States dollar | superseded | [clm_248DF676666D](/claim/clm_248DF676666D.md)
- 2013-12-31 to 2014-12-31 | revenue | 4,374,562,000 United States dollar | superseded | [clm_2C1499ECDFBB](/claim/clm_2C1499ECDFBB.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 378,769,000 United States dollar | superseded | [clm_672148321876](/claim/clm_672148321876.md)
- 2013-12-31 to 2014-03-31 | cash_and_equivalents | 604,965,000 United States dollar | superseded | [clm_921A4AF1D2C2](/claim/clm_921A4AF1D2C2.md)
- 2013-12-31 to 2014-03-31 | total_equity | 1,333,561,000 United States dollar | superseded | [clm_E72E3F6C7D58](/claim/clm_E72E3F6C7D58.md)
- 2013-12-31 to 2014-12-31 | operating_income | 228,347,000 United States dollar | superseded | [clm_F2A235325ECA](/claim/clm_F2A235325ECA.md)
- 2013-12-31 to 2014-12-31 | net_income | 112,403,000 United States dollar | superseded | [clm_F379A778501D](/claim/clm_F379A778501D.md)

## 2014

- 2014-01-30 to 2014-03-31 | shares_outstanding | 59,807,236 shares | superseded | [clm_12C8A314428E](/claim/clm_12C8A314428E.md)
- 2014-02-13 | x_username | netflixfr | unverified | [clm_AFBA53079DCE](/claim/clm_AFBA53079DCE.md)
- 2014-02-13 | x_username | NetflixDE | unverified | [clm_C8C1DFB144A6](/claim/clm_C8C1DFB144A6.md)
- 2014-03-31 to 2014-06-30 | total_assets | 6,048,106,000 United States dollar | superseded | [clm_064B6352F0DE](/claim/clm_064B6352F0DE.md)
- 2014-03-31 to 2014-06-30 | quarterly_revenue | 1,270,089,000 United States dollar | superseded | [clm_0A474F206289](/claim/clm_0A474F206289.md)
- 2014-03-31 to 2014-06-30 | cash_and_equivalents | 1,157,450,000 United States dollar | superseded | [clm_8FD47C89806A](/claim/clm_8FD47C89806A.md)
- 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 110,310,000 United States dollar | superseded | [clm_A945E62EAFF1](/claim/clm_A945E62EAFF1.md)
- 2014-03-31 to 2014-06-30 | quarterly_operating_income | 97,595,000 United States dollar | superseded | [clm_AE92C95B21D0](/claim/clm_AE92C95B21D0.md)
- 2014-03-31 to 2014-06-30 | quarterly_net_income | 53,115,000 United States dollar | superseded | [clm_C2F95CF1BC44](/claim/clm_C2F95CF1BC44.md)
- 2014-03-31 to 2014-06-30 | total_equity | 1,478,358,000 United States dollar | superseded | [clm_F3AC6C1F5C5C](/claim/clm_F3AC6C1F5C5C.md)
- 2014-03-31 to 2014-06-30 | shares_outstanding | 59,940,336 shares | superseded | [clm_FAF01DC1D9E1](/claim/clm_FAF01DC1D9E1.md)
- 2014-06-30 to 2014-09-30 | cash_and_equivalents | 1,214,244,000 United States dollar | superseded | [clm_0FAE2D4201F5](/claim/clm_0FAE2D4201F5.md)
- 2014-06-30 to 2014-09-30 | quarterly_revenue | 1,340,407,000 United States dollar | superseded | [clm_1D103FAD2E0A](/claim/clm_1D103FAD2E0A.md)
- 2014-06-30 to 2014-09-30 | shares_outstanding | 60,091,015 shares | superseded | [clm_2629FBF90225](/claim/clm_2629FBF90225.md)
- 2014-06-30 to 2014-09-30 | total_equity | 1,609,705,000 United States dollar | superseded | [clm_5226D1949DCB](/claim/clm_5226D1949DCB.md)
- 2014-06-30 to 2014-09-30 | quarterly_operating_income | 129,600,000 United States dollar | superseded | [clm_94CC874F3A4D](/claim/clm_94CC874F3A4D.md)
- 2014-06-30 to 2014-09-30 | quarterly_net_income | 71,018,000 United States dollar | superseded | [clm_C92FBF70A2BA](/claim/clm_C92FBF70A2BA.md)
- 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 115,182,000 United States dollar | superseded | [clm_D7048594705C](/claim/clm_D7048594705C.md)
- 2014-06-30 to 2014-09-30 | total_assets | 6,325,822,000 United States dollar | superseded | [clm_E4F822266607](/claim/clm_E4F822266607.md)
- 2014-09-30 to 2015-03-31 | quarterly_revenue | 1,409,432,000 United States dollar | superseded | [clm_0AE274B2C12D](/claim/clm_0AE274B2C12D.md)
- 2014-09-30 to 2015-03-31 | quarterly_operating_income | 110,407,000 United States dollar | superseded | [clm_10F685BE6178](/claim/clm_10F685BE6178.md)
- 2014-09-30 to 2014-12-31 | total_assets | 6,778,329,000 United States dollar | superseded | [clm_689D39947BFA](/claim/clm_689D39947BFA.md)
- 2014-09-30 to 2015-03-31 | quarterly_net_income | 59,295,000 United States dollar | superseded | [clm_946A7D5B98AD](/claim/clm_946A7D5B98AD.md)
- 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 120,953,000 United States dollar | superseded | [clm_B84D0BDDBE21](/claim/clm_B84D0BDDBE21.md)
- 2014-09-30 to 2015-01-28 | shares_outstanding | 60,246,379 shares | superseded | [clm_C10ED8B627A9](/claim/clm_C10ED8B627A9.md)
- 2014-09-30 to 2014-12-31 | cash_and_equivalents | 1,183,217,000 United States dollar | superseded | [clm_DC258441A382](/claim/clm_DC258441A382.md)
- 2014-09-30 to 2014-12-31 | total_equity | 1,724,874,000 United States dollar | superseded | [clm_FAEE35A8F197](/claim/clm_FAEE35A8F197.md)
- 2014-10-02 | x_username | NetflixANZ | unverified | [clm_666B8A3195F0](/claim/clm_666B8A3195F0.md)
- 2014-12-31 to 2015-03-31 | total_assets | 7,056,651,000 United States dollar | superseded | [clm_14C17E3BEFA0](/claim/clm_14C17E3BEFA0.md)
- 2014-12-31 to 2015-12-31 | revenue | 5,504,656,000 United States dollar | superseded | [clm_2FA1BFF7F96D](/claim/clm_2FA1BFF7F96D.md)
- 2014-12-31 to 2015-03-31 | cash_and_equivalents | 1,113,608,000 United States dollar | superseded | [clm_5AA6941C3CD8](/claim/clm_5AA6941C3CD8.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 472,321,000 United States dollar | superseded | [clm_629957AC41EE](/claim/clm_629957AC41EE.md)
- 2014-12-31 to 2015-03-31 | total_equity | 1,857,708,000 United States dollar | superseded | [clm_63F66D622A27](/claim/clm_63F66D622A27.md)
- 2014-12-31 to 2015-12-31 | net_income | 266,799,000 United States dollar | superseded | [clm_69D78950D346](/claim/clm_69D78950D346.md)
- 2014-12-31 to 2015-12-31 | operating_income | 402,648,000 United States dollar | superseded | [clm_9AAC3FE41009](/claim/clm_9AAC3FE41009.md)

## 2015

- 2015-01-28 to 2015-03-31 | shares_outstanding | 60,498,082 shares | superseded | [clm_F83CF4BC7833](/claim/clm_F83CF4BC7833.md)
- 2015-02-18 | x_username | NetflixKR | unverified | [clm_C50F107251F2](/claim/clm_C50F107251F2.md)
- 2015-03-31 to 2015-06-30 | shares_outstanding | 60,620,721 shares | superseded | [clm_2CB7B599F765](/claim/clm_2CB7B599F765.md)
- 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 143,106,000 United States dollar | superseded | [clm_3865561634FB](/claim/clm_3865561634FB.md)
- 2015-03-31 to 2015-06-30 | cash_and_equivalents | 2,454,777,000 United States dollar | superseded | [clm_4920A30C6B20](/claim/clm_4920A30C6B20.md)
- 2015-03-31 to 2015-06-30 | total_assets | 9,240,626,000 United States dollar | superseded | [clm_6E5D72D67F28](/claim/clm_6E5D72D67F28.md)
- 2015-03-31 to 2015-06-30 | total_equity | 1,909,214,000 United States dollar | superseded | [clm_8EA0F874AA16](/claim/clm_8EA0F874AA16.md)
- 2015-03-31 to 2015-06-30 | quarterly_revenue | 1,573,129,000 United States dollar | superseded | [clm_9DCE8862E6A4](/claim/clm_9DCE8862E6A4.md)
- 2015-03-31 to 2015-06-30 | quarterly_operating_income | 97,456,000 United States dollar | superseded | [clm_DCE48D7E575B](/claim/clm_DCE48D7E575B.md)
- 2015-03-31 to 2015-06-30 | quarterly_net_income | 23,696,000 United States dollar | superseded | [clm_DD18F77B0BE2](/claim/clm_DD18F77B0BE2.md)
- 2015-04-07 | x_username | NetflixES | unverified | [clm_D4DFB905BDA4](/claim/clm_D4DFB905BDA4.md)
- 2015-06-06 | x_username | netflixpt | unverified | [clm_0A4B89B8228B](/claim/clm_0A4B89B8228B.md)
- 2015-06-06 | x_username | NetflixIT | unverified | [clm_C0DC77BA9CC9](/claim/clm_C0DC77BA9CC9.md)
- 2015-06-24 | x_username | NetflixJP | unverified | [clm_46A271602EBE](/claim/clm_46A271602EBE.md)
- 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 155,061,000 United States dollar | superseded | [clm_05489F2C39CD](/claim/clm_05489F2C39CD.md)
- 2015-06-30 to 2015-09-30 | quarterly_operating_income | 74,835,000 United States dollar | superseded | [clm_20A6B215613E](/claim/clm_20A6B215613E.md)
- 2015-06-30 to 2015-09-30 | quarterly_net_income | 26,335,000 United States dollar | superseded | [clm_2377BD5F1ABB](/claim/clm_2377BD5F1ABB.md)
- 2015-06-30 to 2015-09-30 | quarterly_revenue | 1,644,694,000 United States dollar | superseded | [clm_5577CEEF300F](/claim/clm_5577CEEF300F.md)
- 2015-06-30 to 2015-09-30 | cash_and_equivalents | 2,293,872,000 United States dollar | superseded | [clm_5991422F8296](/claim/clm_5991422F8296.md)
- 2015-06-30 to 2015-09-30 | shares_outstanding | 426,004,831 shares | superseded | [clm_74651763C76D](/claim/clm_74651763C76D.md)
- 2015-06-30 to 2015-09-30 | total_assets | 9,654,861,000 United States dollar | superseded | [clm_A9486B49C9AC](/claim/clm_A9486B49C9AC.md)
- 2015-06-30 to 2015-09-30 | total_equity | 2,032,075,000 United States dollar | superseded | [clm_DB4183747294](/claim/clm_DB4183747294.md)
- 2015-09-30 to 2015-12-31 | total_assets | 9,916,267,000 United States dollar | superseded | [clm_0F08BCB2A8B1](/claim/clm_0F08BCB2A8B1.md)
- 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 171,762,000 United States dollar | superseded | [clm_4E6E4CFCB269](/claim/clm_4E6E4CFCB269.md)
- 2015-09-30 to 2016-03-31 | quarterly_operating_income | 73,641,000 United States dollar | superseded | [clm_9543958F64C8](/claim/clm_9543958F64C8.md)
- 2015-09-30 to 2015-12-31 | cash_and_equivalents | 2,115,437,000 United States dollar | superseded | [clm_96C992D68BA9](/claim/clm_96C992D68BA9.md)
- 2015-09-30 to 2016-03-31 | quarterly_revenue | 1,738,355,000 United States dollar | superseded | [clm_A70D6A255A66](/claim/clm_A70D6A255A66.md)
- 2015-09-30 to 2016-03-31 | quarterly_net_income | 29,432,000 United States dollar | superseded | [clm_D99B763D5C77](/claim/clm_D99B763D5C77.md)
- 2015-09-30 to 2015-12-31 | total_equity | 2,167,318,000 United States dollar | superseded | [clm_E008A4FCA091](/claim/clm_E008A4FCA091.md)
- 2015-09-30 to 2016-01-27 | shares_outstanding | 427,388,288 shares | superseded | [clm_FE941B9B3512](/claim/clm_FE941B9B3512.md)
- 2015-12-03 | x_username | NetflixMY | unverified | [clm_146B09758ACA](/claim/clm_146B09758ACA.md)
- 2015-12-09 | x_username | NetflixIndia | unverified | [clm_5D3F5EBDE330](/claim/clm_5D3F5EBDE330.md)
- 2015-12-29 | x_username | NetflixMENA | unverified | [clm_7F0011B62DC3](/claim/clm_7F0011B62DC3.md)
- 2015-12-31 to 2016-03-31 | total_equity | 2,223,426,000 United States dollar | superseded | [clm_3C1DAF520DED](/claim/clm_3C1DAF520DED.md)
- 2015-12-31 to 2016-03-31 | total_assets | 10,202,871,000 United States dollar | superseded | [clm_3EA4BE8B1DE0](/claim/clm_3EA4BE8B1DE0.md)
- 2015-12-31 to 2016-12-31 | operating_income | 305,826,000 United States dollar | superseded | [clm_62FD580C0D6B](/claim/clm_62FD580C0D6B.md)
- 2015-12-31 to 2016-03-31 | cash_and_equivalents | 1,809,330,000 United States dollar | superseded | [clm_A5BE56F6DFF3](/claim/clm_A5BE56F6DFF3.md)
- 2015-12-31 to 2016-12-31 | net_income | 122,641,000 United States dollar | superseded | [clm_BCFB30F9316D](/claim/clm_BCFB30F9316D.md)
- 2015-12-31 to 2016-12-31 | revenue | 6,779,511,000 United States dollar | superseded | [clm_D95A21D4E1C6](/claim/clm_D95A21D4E1C6.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 650,788,000 United States dollar | superseded | [clm_DC456979D775](/claim/clm_DC456979D775.md)

## 2016

- 2016-01-07 | x_username | netflixturkiye | unverified | [clm_726AA2C842CC](/claim/clm_726AA2C842CC.md)
- 2016-01-27 to 2016-03-31 | shares_outstanding | 428,081,221 shares | superseded | [clm_C49CA77C2055](/claim/clm_C49CA77C2055.md)
- 2016-03-31 to 2016-06-30 | total_equity | 2,317,233,000 United States dollar | superseded | [clm_30665B974B13](/claim/clm_30665B974B13.md)
- 2016-03-31 to 2016-06-30 | quarterly_net_income | 27,658,000 United States dollar | superseded | [clm_564A95069F97](/claim/clm_564A95069F97.md)
- 2016-03-31 to 2016-06-30 | shares_outstanding | 428,289,216 shares | superseded | [clm_60610B95B76D](/claim/clm_60610B95B76D.md)
- 2016-03-31 to 2016-06-30 | cash_and_equivalents | 1,605,244,000 United States dollar | superseded | [clm_7366A0A2CAA3](/claim/clm_7366A0A2CAA3.md)
- 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 203,508,000 United States dollar | superseded | [clm_B0B36E511DD2](/claim/clm_B0B36E511DD2.md)
- 2016-03-31 to 2016-06-30 | quarterly_operating_income | 49,453,000 United States dollar | superseded | [clm_E2CADB81D46D](/claim/clm_E2CADB81D46D.md)
- 2016-03-31 to 2016-06-30 | total_assets | 11,262,274,000 United States dollar | superseded | [clm_F2FE9D1C69E2](/claim/clm_F2FE9D1C69E2.md)
- 2016-03-31 to 2016-06-30 | quarterly_revenue | 1,957,736,000 United States dollar | superseded | [clm_FB9E84A79752](/claim/clm_FB9E84A79752.md)
- 2016-06-30 to 2016-09-30 | quarterly_revenue | 2,105,204,000 United States dollar | superseded | [clm_06843618884D](/claim/clm_06843618884D.md)
- 2016-06-30 to 2016-09-30 | total_assets | 11,593,507,000 United States dollar | superseded | [clm_073FB22C0CF0](/claim/clm_073FB22C0CF0.md)
- 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 207,300,000 United States dollar | superseded | [clm_2BF43BC07610](/claim/clm_2BF43BC07610.md)
- 2016-06-30 to 2016-09-30 | cash_and_equivalents | 1,390,925,000 United States dollar | superseded | [clm_7C093A14744A](/claim/clm_7C093A14744A.md)
- 2016-06-30 to 2016-09-30 | quarterly_net_income | 40,755,000 United States dollar | superseded | [clm_91A6398D1C11](/claim/clm_91A6398D1C11.md)
- 2016-06-30 to 2016-09-30 | shares_outstanding | 428,725,388 shares | superseded | [clm_A7C650E861EE](/claim/clm_A7C650E861EE.md)
- 2016-06-30 to 2016-09-30 | total_equity | 2,415,834,000 United States dollar | superseded | [clm_D0E0FE69BE35](/claim/clm_D0E0FE69BE35.md)
- 2016-06-30 to 2016-09-30 | quarterly_operating_income | 70,370,000 United States dollar | superseded | [clm_EF3350B30135](/claim/clm_EF3350B30135.md)
- 2016-08-11 | x_username | Netflix_PH | unverified | [clm_8AFD72BB1750](/claim/clm_8AFD72BB1750.md)
- 2016-09-30 to 2017-01-26 | shares_outstanding | 429,145,023 shares | superseded | [clm_031539CF7B73](/claim/clm_031539CF7B73.md)
- 2016-09-30 to 2016-12-31 | total_equity | 2,528,966,000 United States dollar | superseded | [clm_26301B80AC4D](/claim/clm_26301B80AC4D.md)
- 2016-09-30 to 2016-12-31 | total_assets | 12,347,338,000 United States dollar | superseded | [clm_4DC3D01AAE28](/claim/clm_4DC3D01AAE28.md)
- 2016-09-30 to 2016-12-31 | cash_and_equivalents | 969,158,000 United States dollar | superseded | [clm_4F6D873F3CB5](/claim/clm_4F6D873F3CB5.md)
- 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 216,099,000 United States dollar | superseded | [clm_B4C32E244CDB](/claim/clm_B4C32E244CDB.md)
- 2016-09-30 to 2017-03-31 | quarterly_revenue | 2,290,188,000 United States dollar | superseded | [clm_BFA20E87E45E](/claim/clm_BFA20E87E45E.md)
- 2016-09-30 to 2017-03-31 | quarterly_net_income | 51,517,000 United States dollar | superseded | [clm_C0D0D40B20AC](/claim/clm_C0D0D40B20AC.md)
- 2016-09-30 to 2017-03-31 | quarterly_operating_income | 106,036,000 United States dollar | superseded | [clm_F59C0D6E991C](/claim/clm_F59C0D6E991C.md)
- 2016-12-31 to 2017-03-31 | cash_and_equivalents | 1,467,576,000 United States dollar | superseded | [clm_04E50D365A8E](/claim/clm_04E50D365A8E.md)
- 2016-12-31 to 2017-12-31 | operating_income | 379,793,000 United States dollar | superseded | [clm_18AAE2B5C1DC](/claim/clm_18AAE2B5C1DC.md)
- 2016-12-31 to 2017-03-31 | total_assets | 13,586,610,000 United States dollar | superseded | [clm_1A87F01CB239](/claim/clm_1A87F01CB239.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 768,300,000 United States dollar | superseded | [clm_2169E738F95F](/claim/clm_2169E738F95F.md)
- 2016-12-31 to 2017-12-31 | revenue | 8,830,669,000 United States dollar | superseded | [clm_5BC58A347748](/claim/clm_5BC58A347748.md)
- 2016-12-31 to 2017-12-31 | net_income | 186,678,000 United States dollar | superseded | [clm_88264D26C831](/claim/clm_88264D26C831.md)
- 2016-12-31 to 2017-03-31 | total_equity | 2,679,800,000 United States dollar | superseded | [clm_92ABD1877370](/claim/clm_92ABD1877370.md)

## 2017

- 2017-01-26 to 2017-03-31 | shares_outstanding | 430,411,593 shares | superseded | [clm_8B975DD2D615](/claim/clm_8B975DD2D615.md)
- 2017-03-31 to 2017-06-30 | shares_outstanding | 430,993,429 shares | superseded | [clm_28EA7DC8AA3B](/claim/clm_28EA7DC8AA3B.md)
- 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 257,108,000 United States dollar | superseded | [clm_5091454DF7EA](/claim/clm_5091454DF7EA.md)
- 2017-03-31 to 2017-06-30 | cash_and_equivalents | 1,077,824,000 United States dollar | superseded | [clm_5626E911E2D7](/claim/clm_5626E911E2D7.md)
- 2017-03-31 to 2017-06-30 | quarterly_revenue | 2,636,635,000 United States dollar | superseded | [clm_9B6BBBCB12E9](/claim/clm_9B6BBBCB12E9.md)
- 2017-03-31 to 2017-06-30 | quarterly_operating_income | 256,942,000 United States dollar | superseded | [clm_A35E73564089](/claim/clm_A35E73564089.md)
- 2017-03-31 to 2017-06-30 | total_assets | 14,359,096,000 United States dollar | superseded | [clm_AB534D2F0310](/claim/clm_AB534D2F0310.md)
- 2017-03-31 to 2017-06-30 | total_equity | 2,973,683,000 United States dollar | superseded | [clm_E08BF414B87B](/claim/clm_E08BF414B87B.md)
- 2017-03-31 to 2017-06-30 | quarterly_net_income | 178,222,000 United States dollar | superseded | [clm_ED0A727C78C4](/claim/clm_ED0A727C78C4.md)
- 2017-04-25 | x_username | netflixth | unverified | [clm_1542087907C3](/claim/clm_1542087907C3.md)
- 2017-06-30 to 2017-09-30 | shares_outstanding | 431,749,744 shares | superseded | [clm_21A952A50E4C](/claim/clm_21A952A50E4C.md)
- 2017-06-30 to 2017-09-30 | total_assets | 16,517,223,000 United States dollar | superseded | [clm_25647BE66D93](/claim/clm_25647BE66D93.md)
- 2017-06-30 to 2017-09-30 | quarterly_revenue | 2,785,464,000 United States dollar | superseded | [clm_37071284F601](/claim/clm_37071284F601.md)
- 2017-06-30 to 2017-09-30 | quarterly_net_income | 65,600,000 United States dollar | superseded | [clm_5525D67CAD30](/claim/clm_5525D67CAD30.md)
- 2017-06-30 to 2017-09-30 | cash_and_equivalents | 1,918,777,000 United States dollar | superseded | [clm_6CD9E9D07B7D](/claim/clm_6CD9E9D07B7D.md)
- 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 267,083,000 United States dollar | superseded | [clm_BCF261B4F385](/claim/clm_BCF261B4F385.md)
- 2017-06-30 to 2017-09-30 | total_equity | 3,112,500,000 United States dollar | superseded | [clm_E7A5F9DB7E60](/claim/clm_E7A5F9DB7E60.md)
- 2017-06-30 to 2017-09-30 | quarterly_operating_income | 127,807,000 United States dollar | superseded | [clm_F79839C81DE5](/claim/clm_F79839C81DE5.md)
- 2017-09-17 | x_username | netflixfamily | unverified | [clm_876987F14A3B](/claim/clm_876987F14A3B.md)
- 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 255,236,000 United States dollar | superseded | [clm_1C5CD0ED33DE](/claim/clm_1C5CD0ED33DE.md)
- 2017-09-30 to 2018-03-31 | quarterly_revenue | 2,984,859,000 United States dollar | superseded | [clm_34CB557B0C11](/claim/clm_34CB557B0C11.md)
- 2017-09-30 to 2017-12-31 | total_equity | 3,327,361,000 United States dollar | superseded | [clm_34F05B4FBA43](/claim/clm_34F05B4FBA43.md)
- 2017-09-30 to 2018-03-31 | quarterly_operating_income | 208,627,000 United States dollar | superseded | [clm_447FA896539B](/claim/clm_447FA896539B.md)
- 2017-09-30 to 2018-03-31 | quarterly_net_income | 129,590,000 United States dollar | superseded | [clm_56EE8D0A5B67](/claim/clm_56EE8D0A5B67.md)
- 2017-09-30 to 2017-12-31 | cash_and_equivalents | 1,746,469,000 United States dollar | superseded | [clm_BC9A9C15BF92](/claim/clm_BC9A9C15BF92.md)
- 2017-09-30 to 2017-12-31 | total_assets | 16,951,540,000 United States dollar | superseded | [clm_C0E3C27602E3](/claim/clm_C0E3C27602E3.md)
- 2017-09-30 to 2018-01-25 | shares_outstanding | 432,731,130 shares | superseded | [clm_E2B304AC6733](/claim/clm_E2B304AC6733.md)
- 2017-12-08 | x_username | NetflixSA | unverified | [clm_F4CAD8212B3E](/claim/clm_F4CAD8212B3E.md)
- 2017-12-31 to 2018-03-31 | cash_and_equivalents | 2,822,795,000 United States dollar | superseded | [clm_5A1E6623F2AC](/claim/clm_5A1E6623F2AC.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 981,300,000 United States dollar | superseded | [clm_60E85CB32E2C](/claim/clm_60E85CB32E2C.md)
- 2017-12-31 to 2018-12-31 | operating_income | 838,679,000 United States dollar | superseded | [clm_9A94485C31FD](/claim/clm_9A94485C31FD.md)
- 2017-12-31 to 2018-12-31 | revenue | 11,692,713,000 United States dollar | superseded | [clm_A22FACB756A4](/claim/clm_A22FACB756A4.md)
- 2017-12-31 to 2018-03-31 | total_equity | 3,581,956,000 United States dollar | superseded | [clm_A6A7C2D817CE](/claim/clm_A6A7C2D817CE.md)
- 2017-12-31 to 2018-03-31 | total_assets | 19,012,742,000 United States dollar | superseded | [clm_C3CB34E81A13](/claim/clm_C3CB34E81A13.md)
- 2017-12-31 to 2018-12-31 | net_income | 558,929,000 United States dollar | superseded | [clm_D861BA5EAF62](/claim/clm_D861BA5EAF62.md)

## 2018

- 2018-01-25 to 2018-03-31 | shares_outstanding | 433,948,461 shares | superseded | [clm_FC0FB36B6799](/claim/clm_FC0FB36B6799.md)
- 2018-03-14 | x_username | NetflixJP_Anime | unverified | [clm_0ECABE0C238E](/claim/clm_0ECABE0C238E.md)
- 2018-03-21 | x_username | NetflixFilm | unverified | [clm_CD8E9BDC2C9A](/claim/clm_CD8E9BDC2C9A.md)
- 2018-03-31 to 2018-06-30 | quarterly_revenue | 3,700,856,000 United States dollar | superseded | [clm_54536BFA47A9](/claim/clm_54536BFA47A9.md)
- 2018-03-31 to 2018-06-30 | total_assets | 20,152,797,000 United States dollar | superseded | [clm_573614AD76C7](/claim/clm_573614AD76C7.md)
- 2018-03-31 to 2018-06-30 | shares_outstanding | 434,657,303 shares | superseded | [clm_70038C983F38](/claim/clm_70038C983F38.md)
- 2018-03-31 to 2018-06-30 | quarterly_net_income | 290,124,000 United States dollar | superseded | [clm_981101D5FBAA](/claim/clm_981101D5FBAA.md)
- 2018-03-31 to 2018-06-30 | cash_and_equivalents | 2,593,666,000 United States dollar | superseded | [clm_BB32B03AAD7E](/claim/clm_BB32B03AAD7E.md)
- 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 300,730,000 United States dollar | superseded | [clm_DADA3F11CA21](/claim/clm_DADA3F11CA21.md)
- 2018-03-31 to 2018-06-30 | total_equity | 4,020,730,000 United States dollar | superseded | [clm_ECC99093A7CC](/claim/clm_ECC99093A7CC.md)
- 2018-03-31 to 2018-06-30 | quarterly_operating_income | 446,578,000 United States dollar | superseded | [clm_F6E3601B2A43](/claim/clm_F6E3601B2A43.md)
- 2018-05-24 | x_username | NetflixGeeked | unverified | [clm_DF774AEE0BFA](/claim/clm_DF774AEE0BFA.md)
- 2018-06-30 to 2018-09-30 | quarterly_revenue | 3,907,270,000 United States dollar | superseded | [clm_0B36B5C476E3](/claim/clm_0B36B5C476E3.md)
- 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 317,213,000 United States dollar | superseded | [clm_0E2305EAEB0E](/claim/clm_0E2305EAEB0E.md)
- 2018-06-30 to 2018-09-30 | total_equity | 4,496,600,000 United States dollar | superseded | [clm_9B2DC56DB686](/claim/clm_9B2DC56DB686.md)
- 2018-06-30 to 2018-09-30 | quarterly_net_income | 384,349,000 United States dollar | superseded | [clm_ABF29E7E87BA](/claim/clm_ABF29E7E87BA.md)
- 2018-06-30 to 2018-09-30 | cash_and_equivalents | 3,906,357,000 United States dollar | superseded | [clm_B789A2386D55](/claim/clm_B789A2386D55.md)
- 2018-06-30 to 2018-09-30 | total_assets | 22,663,537,000 United States dollar | superseded | [clm_D86998695CFC](/claim/clm_D86998695CFC.md)
- 2018-06-30 to 2018-09-30 | shares_outstanding | 435,457,505 shares | superseded | [clm_E5AA4CEDFEA7](/claim/clm_E5AA4CEDFEA7.md)
- 2018-06-30 to 2018-09-30 | quarterly_operating_income | 462,213,000 United States dollar | superseded | [clm_FFBF16243C58](/claim/clm_FFBF16243C58.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 3,067,534,000 United States dollar | superseded | [clm_0A4F27F21281](/claim/clm_0A4F27F21281.md)
- 2018-09-30 to 2018-12-31 | shares_outstanding | 436,084,995 shares | superseded | [clm_0E444CFA8035](/claim/clm_0E444CFA8035.md)
- 2018-09-30 to 2019-03-31 | quarterly_revenue | 3,999,374,000 United States dollar | superseded | [clm_0F896DFCC9D1](/claim/clm_0F896DFCC9D1.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | 402,835,000 United States dollar | superseded | [clm_6E675E682D27](/claim/clm_6E675E682D27.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | 480,668,000 United States dollar | superseded | [clm_8BDB9F843825](/claim/clm_8BDB9F843825.md)
- 2018-09-30 to 2018-12-31 | total_equity | 5,009,653,000 United States dollar | superseded | [clm_A49C4B1AA103](/claim/clm_A49C4B1AA103.md)
- 2018-09-30 to 2018-12-31 | total_assets | 23,366,229,000 United States dollar | superseded | [clm_D11A6057EAD9](/claim/clm_D11A6057EAD9.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 327,026,000 United States dollar | superseded | [clm_F69A01D5299F](/claim/clm_F69A01D5299F.md)
- 2018-12-31 to 2019-12-31 | operating_income | 1,605,226,000 United States dollar | superseded | [clm_28B2326FDAA7](/claim/clm_28B2326FDAA7.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 1,210,000,000 United States dollar | superseded | [clm_566893AAD439](/claim/clm_566893AAD439.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 3,794,483,000 United States dollar | superseded | [clm_5F1C61EAA39F](/claim/clm_5F1C61EAA39F.md)
- 2018-12-31 to 2019-12-31 | net_income | 1,211,242,000 United States dollar | superseded | [clm_8B5F0C6CAE7F](/claim/clm_8B5F0C6CAE7F.md)
- 2018-12-31 to 2019-03-31 | shares_outstanding | 436,598,597 shares | superseded | [clm_969FB308AB35](/claim/clm_969FB308AB35.md)
- 2018-12-31 to 2019-03-31 | total_assets | 25,974,400,000 United States dollar | superseded | [clm_BBE6D27EE0BC](/claim/clm_BBE6D27EE0BC.md)
- 2018-12-31 to 2019-12-31 | revenue | 15,794,341,000 United States dollar | superseded | [clm_BE8AF209109F](/claim/clm_BE8AF209109F.md)
- 2018-12-31 to 2019-03-31 | total_equity | 5,238,765,000 United States dollar | superseded | [clm_CCDD77B39C7C](/claim/clm_CCDD77B39C7C.md)

## 2019

- 2019-03-14 | x_username | CheNetflix | unverified | [clm_A8E2483339DC](/claim/clm_A8E2483339DC.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 3,348,557,000 United States dollar | superseded | [clm_022C06226E5F](/claim/clm_022C06226E5F.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 372,764,000 United States dollar | superseded | [clm_42FDE57C56E7](/claim/clm_42FDE57C56E7.md)
- 2019-03-31 to 2019-06-30 | quarterly_revenue | 4,520,992,000 United States dollar | superseded | [clm_4CC9997B5F15](/claim/clm_4CC9997B5F15.md)
- 2019-03-31 to 2019-06-30 | total_assets | 27,218,632,000 United States dollar | superseded | [clm_9BC46FEA4228](/claim/clm_9BC46FEA4228.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | 344,052,000 United States dollar | superseded | [clm_A995F0D7516B](/claim/clm_A995F0D7516B.md)
- 2019-03-31 to 2019-06-30 | shares_outstanding | 437,191,891 shares | superseded | [clm_C75D0084AB58](/claim/clm_C75D0084AB58.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | 459,084,000 United States dollar | superseded | [clm_F90F8878FB2C](/claim/clm_F90F8878FB2C.md)
- 2019-03-31 to 2019-06-30 | total_equity | 5,703,058,000 United States dollar | superseded | [clm_FABF4E2E5291](/claim/clm_FABF4E2E5291.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 383,233,000 United States dollar | superseded | [clm_082124A5C57D](/claim/clm_082124A5C57D.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | 706,419,000 United States dollar | superseded | [clm_0920F7AAF7C5](/claim/clm_0920F7AAF7C5.md)
- 2019-06-30 to 2019-09-30 | total_equity | 6,105,548,000 United States dollar | superseded | [clm_29C9DB0A302A](/claim/clm_29C9DB0A302A.md)
- 2019-06-30 to 2019-09-30 | quarterly_revenue | 4,923,116,000 United States dollar | superseded | [clm_603FA13FCA07](/claim/clm_603FA13FCA07.md)
- 2019-06-30 to 2019-09-30 | shares_outstanding | 437,834,882 shares | superseded | [clm_8D1A81DA1B56](/claim/clm_8D1A81DA1B56.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 5,004,247,000 United States dollar | superseded | [clm_BA7990A949C0](/claim/clm_BA7990A949C0.md)
- 2019-06-30 to 2019-09-30 | total_assets | 30,171,339,000 United States dollar | superseded | [clm_D10CAABCEE9C](/claim/clm_D10CAABCEE9C.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | 270,650,000 United States dollar | superseded | [clm_D76E9902299D](/claim/clm_D76E9902299D.md)
- 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 379,776,000 United States dollar | superseded | [clm_3008B6C907CD](/claim/clm_3008B6C907CD.md)
- 2019-09-30 to 2019-12-31 | total_equity | 6,861,505,000 United States dollar | superseded | [clm_5533AE1862DA](/claim/clm_5533AE1862DA.md)
- 2019-09-30 to 2020-03-31 | quarterly_revenue | 5,244,905,000 United States dollar | superseded | [clm_BEB36DC31E01](/claim/clm_BEB36DC31E01.md)
- 2019-09-30 to 2019-12-31 | shares_outstanding | 438,251,289 shares | superseded | [clm_CC0C74DB9207](/claim/clm_CC0C74DB9207.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 4,435,018,000 United States dollar | superseded | [clm_D68B9BBA446D](/claim/clm_D68B9BBA446D.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | 980,239,000 United States dollar | superseded | [clm_ED9309C3D58D](/claim/clm_ED9309C3D58D.md)
- 2019-09-30 to 2019-12-31 | total_assets | 30,941,711,000 United States dollar | superseded | [clm_F230BA91E421](/claim/clm_F230BA91E421.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | 665,244,000 United States dollar | superseded | [clm_FF99869D6CF0](/claim/clm_FF99869D6CF0.md)
- 2019-11-23 | x_username | seewhatsnext | unverified | [clm_A3EBEA45A836](/claim/clm_A3EBEA45A836.md)
- 2019-12-05 | x_username | contodonetflix | unverified | [clm_502A899AF256](/claim/clm_502A899AF256.md)
- 2019-12-31 to 2020-03-31 | total_equity | 7,582,157,000 United States dollar | superseded | [clm_230503F0BE64](/claim/clm_230503F0BE64.md)
- 2019-12-31 to 2020-03-31 | shares_outstanding | 438,806,649 shares | superseded | [clm_3FBE6FCB82C2](/claim/clm_3FBE6FCB82C2.md)
- 2019-12-31 to 2020-12-31 | operating_income | 2,604,254,000 United States dollar | superseded | [clm_5877F9F4D384](/claim/clm_5877F9F4D384.md)
- 2019-12-31 to 2020-12-31 | revenue | 20,156,447,000 United States dollar | superseded | [clm_5BC44FBC3D01](/claim/clm_5BC44FBC3D01.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 1,673,000,000 United States dollar | superseded | [clm_70C242673688](/claim/clm_70C242673688.md)
- 2019-12-31 to 2020-03-31 | total_assets | 33,975,712,000 United States dollar | superseded | [clm_854E4D8FC024](/claim/clm_854E4D8FC024.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 5,018,437,000 United States dollar | superseded | [clm_B680ED5FE026](/claim/clm_B680ED5FE026.md)
- 2019-12-31 to 2020-12-31 | net_income | 1,866,916,000 United States dollar | superseded | [clm_D66DCE5538CA](/claim/clm_D66DCE5538CA.md)

## 2020

- 2020-01-01 to 2025-04-17 | chair | Ted Sarandos | superseded | [clm_1342830FD8CE](/claim/clm_1342830FD8CE.md)
- 2020-02-25 | x_username | NetflixNaija | unverified | [clm_525B3CD80E75](/claim/clm_525B3CD80E75.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | 958,256,000 United States dollar | superseded | [clm_007BEDA0FC0D](/claim/clm_007BEDA0FC0D.md)
- 2020-03-31 to 2020-06-30 | total_equity | 8,409,294,000 United States dollar | superseded | [clm_01E1BF064E58](/claim/clm_01E1BF064E58.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | 709,067,000 United States dollar | superseded | [clm_0D0AEEB5C8B5](/claim/clm_0D0AEEB5C8B5.md)
- 2020-03-31 to 2020-06-30 | total_assets | 35,059,910,000 United States dollar | superseded | [clm_15746141454A](/claim/clm_15746141454A.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 453,817,000 United States dollar | superseded | [clm_A4D496F0084C](/claim/clm_A4D496F0084C.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 5,767,691,000 United States dollar | superseded | [clm_E2FC416EC33F](/claim/clm_E2FC416EC33F.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 5,151,884,000 United States dollar | superseded | [clm_F5E2C2FB9A1F](/claim/clm_F5E2C2FB9A1F.md)
- 2020-03-31 to 2020-06-30 | shares_outstanding | 439,780,618 shares | superseded | [clm_F7182CFF253F](/claim/clm_F7182CFF253F.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | 1,357,928,000 United States dollar | superseded | [clm_0DB06B237D04](/claim/clm_0DB06B237D04.md)
- 2020-06-30 to 2020-09-30 | total_assets | 37,175,281,000 United States dollar | superseded | [clm_104743EBE534](/claim/clm_104743EBE534.md)
- 2020-06-30 to 2020-09-30 | total_equity | 9,334,753,000 United States dollar | superseded | [clm_3AC37528BFF6](/claim/clm_3AC37528BFF6.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 7,153,248,000 United States dollar | superseded | [clm_7936BA43E69B](/claim/clm_7936BA43E69B.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | 720,196,000 United States dollar | superseded | [clm_85B70BDDD422](/claim/clm_85B70BDDD422.md)
- 2020-06-30 to 2020-09-30 | shares_outstanding | 441,015,443 shares | superseded | [clm_BD9DEF927CA1](/claim/clm_BD9DEF927CA1.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 435,045,000 United States dollar | superseded | [clm_C5B8CF40FA8A](/claim/clm_C5B8CF40FA8A.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 6,148,286,000 United States dollar | superseded | [clm_E9CD01FB5D4E](/claim/clm_E9CD01FB5D4E.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 8,392,391,000 United States dollar | superseded | [clm_325F82AE8A85](/claim/clm_325F82AE8A85.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | 1,314,863,000 United States dollar | superseded | [clm_3EED40166213](/claim/clm_3EED40166213.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | 789,976,000 United States dollar | superseded | [clm_74604627F9D1](/claim/clm_74604627F9D1.md)
- 2020-09-30 to 2020-12-31 | total_equity | 10,333,323,000 United States dollar | superseded | [clm_840099EB8363](/claim/clm_840099EB8363.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 453,802,000 United States dollar | superseded | [clm_870412FBA992](/claim/clm_870412FBA992.md)
- 2020-09-30 to 2020-12-31 | total_assets | 38,622,543,000 United States dollar | superseded | [clm_A6379B1DBD2D](/claim/clm_A6379B1DBD2D.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 6,435,637,000 United States dollar | superseded | [clm_D949D771EAE4](/claim/clm_D949D771EAE4.md)
- 2020-09-30 to 2020-12-31 | shares_outstanding | 441,795,008 shares | superseded | [clm_DE4AD7D5D157](/claim/clm_DE4AD7D5D157.md)
- 2020-12-31 to 2021-12-31 | revenue | 24,996,056,000 United States dollar | superseded | [clm_0633C0FF18E8](/claim/clm_0633C0FF18E8.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 1,984,000,000 United States dollar | superseded | [clm_069D330128B1](/claim/clm_069D330128B1.md)
- 2020-12-31 to 2021-03-31 | total_assets | 39,280,359,000 United States dollar | superseded | [clm_20C8A53DD225](/claim/clm_20C8A53DD225.md)
- 2020-12-31 to 2021-03-31 | total_equity | 11,065,240,000 United States dollar | superseded | [clm_457081C17541](/claim/clm_457081C17541.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 8,205,550,000 United States dollar | superseded | [clm_7530B183C7C0](/claim/clm_7530B183C7C0.md)
- 2020-12-31 to 2021-12-31 | operating_income | 4,585,289,000 United States dollar | superseded | [clm_8C3296557F96](/claim/clm_8C3296557F96.md)
- 2020-12-31 to 2021-03-31 | shares_outstanding | 442,895,261 shares | superseded | [clm_8D7D5B22F004](/claim/clm_8D7D5B22F004.md)
- 2020-12-31 to 2021-12-31 | net_income | 2,761,395,000 United States dollar | superseded | [clm_B8CE78AA3410](/claim/clm_B8CE78AA3410.md)

## 2021

- 2021-03-31 to 2021-06-30 | total_equity | 12,884,080,000 United States dollar | superseded | [clm_18B4472F3215](/claim/clm_18B4472F3215.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 8,403,705,000 United States dollar | superseded | [clm_23506C8785C0](/claim/clm_23506C8785C0.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | 1,706,715,000 United States dollar | superseded | [clm_2C8641B37E54](/claim/clm_2C8641B37E54.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 7,163,282,000 United States dollar | superseded | [clm_3A6238F53F18](/claim/clm_3A6238F53F18.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 525,207,000 United States dollar | superseded | [clm_3ECA3F9F3FF9](/claim/clm_3ECA3F9F3FF9.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | 1,959,856,000 United States dollar | superseded | [clm_C15C78AE62F7](/claim/clm_C15C78AE62F7.md)
- 2021-03-31 to 2021-06-30 | total_assets | 40,123,014,000 United States dollar | superseded | [clm_CC6938E507CF](/claim/clm_CC6938E507CF.md)
- 2021-03-31 to 2021-06-30 | shares_outstanding | 443,383,732 shares | superseded | [clm_EC18243A6908](/claim/clm_EC18243A6908.md)
- 2021-06-30 to 2021-09-30 | total_assets | 40,970,969,000 United States dollar | superseded | [clm_0EEA80E2210F](/claim/clm_0EEA80E2210F.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 7,341,777,000 United States dollar | superseded | [clm_1655DCCAEFBF](/claim/clm_1655DCCAEFBF.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | 1,847,630,000 United States dollar | superseded | [clm_19A510DB7052](/claim/clm_19A510DB7052.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 7,777,530,000 United States dollar | superseded | [clm_38068699D008](/claim/clm_38068699D008.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 537,321,000 United States dollar | superseded | [clm_840F8010007A](/claim/clm_840F8010007A.md)
- 2021-06-30 to 2021-09-30 | total_equity | 13,863,871,000 United States dollar | superseded | [clm_8B7250F1B18E](/claim/clm_8B7250F1B18E.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | 1,353,013,000 United States dollar | superseded | [clm_E6004322B27F](/claim/clm_E6004322B27F.md)
- 2021-06-30 to 2021-09-30 | shares_outstanding | 442,595,888 shares | superseded | [clm_F66FCD8A660F](/claim/clm_F66FCD8A660F.md)
- 2021-07-02 | x_username | Netflix_INSouth | unverified | [clm_BD1F80DDD2C3](/claim/clm_BD1F80DDD2C3.md)
- 2021-09-23 | x_username | NetflixKE | unverified | [clm_6AF6E3CE6F2D](/claim/clm_6AF6E3CE6F2D.md)
- 2021-09-30 to 2021-12-31 | total_assets | 42,739,857,000 United States dollar | superseded | [clm_7C4FE5F54F5F](/claim/clm_7C4FE5F54F5F.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | 1,755,253,000 United States dollar | superseded | [clm_92EC13665E75](/claim/clm_92EC13665E75.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 7,526,681,000 United States dollar | superseded | [clm_98BABCD44C7D](/claim/clm_98BABCD44C7D.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | 1,449,071,000 United States dollar | superseded | [clm_AB042CD957E7](/claim/clm_AB042CD957E7.md)
- 2021-09-30 to 2021-12-31 | shares_outstanding | 442,952,194 shares | superseded | [clm_AFBD334DD3BF](/claim/clm_AFBD334DD3BF.md)
- 2021-09-30 to 2021-12-31 | total_equity | 15,314,617,000 United States dollar | superseded | [clm_C2AEBDF8FB06](/claim/clm_C2AEBDF8FB06.md)
- 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 563,887,000 United States dollar | superseded | [clm_ED6613295D73](/claim/clm_ED6613295D73.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 7,483,467,000 United States dollar | superseded | [clm_F890CF008212](/claim/clm_F890CF008212.md)
- 2021-12-31 to 2022-03-31 | total_assets | 44,584,663,000 United States dollar | superseded | [clm_00E248FBC4EF](/claim/clm_00E248FBC4EF.md)
- 2021-12-31 to 2022-03-31 | shares_outstanding | 443,963,107 shares | superseded | [clm_1AF03E38BFB9](/claim/clm_1AF03E38BFB9.md)
- 2021-12-31 to 2022-12-31 | operating_income | 6,194,509,000 United States dollar | superseded | [clm_205B4C83FB63](/claim/clm_205B4C83FB63.md)
- 2021-12-31 to 2022-12-31 | net_income | 5,116,228,000 United States dollar | superseded | [clm_60E5BD9270D2](/claim/clm_60E5BD9270D2.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 2,273,885,000 United States dollar | superseded | [clm_6937797C6505](/claim/clm_6937797C6505.md)
- 2021-12-31 to 2022-03-31 | total_equity | 15,849,248,000 United States dollar | superseded | [clm_72A37DA1C15D](/claim/clm_72A37DA1C15D.md)
- 2021-12-31 to 2022-12-31 | revenue | 29,697,844,000 United States dollar | superseded | [clm_AAF0784D2792](/claim/clm_AAF0784D2792.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 6,027,804,000 United States dollar | superseded | [clm_E1B459794EBF](/claim/clm_E1B459794EBF.md)

## 2022

- 2022-03-31 to 2022-06-30 | total_assets | 45,330,904,000 United States dollar | superseded | [clm_15ED64406B93](/claim/clm_15ED64406B93.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 7,867,767,000 United States dollar | superseded | [clm_387B6F1A971D](/claim/clm_387B6F1A971D.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | 1,971,626,000 United States dollar | superseded | [clm_3AD5354D9869](/claim/clm_3AD5354D9869.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | 1,597,447,000 United States dollar | superseded | [clm_6E5596C3CD18](/claim/clm_6E5596C3CD18.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 6,008,946,000 United States dollar | superseded | [clm_824633AEC0BF](/claim/clm_824633AEC0BF.md)
- 2022-03-31 to 2022-06-30 | total_equity | 17,544,039,000 United States dollar | superseded | [clm_D61E481D4EA3](/claim/clm_D61E481D4EA3.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 657,530,000 United States dollar | superseded | [clm_DA1628A2014A](/claim/clm_DA1628A2014A.md)
- 2022-03-31 to 2022-06-30 | shares_outstanding | 444,273,850 shares | superseded | [clm_E5889B0FE8E2](/claim/clm_E5889B0FE8E2.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | 1,578,283,000 United States dollar | superseded | [clm_6C228C5B45A5](/claim/clm_6C228C5B45A5.md)
- 2022-06-30 to 2022-09-30 | total_equity | 19,075,974,000 United States dollar | superseded | [clm_6ECEDC6AB0C0](/claim/clm_6ECEDC6AB0C0.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 716,846,000 United States dollar | superseded | [clm_ADBBC94202DE](/claim/clm_ADBBC94202DE.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 7,970,141,000 United States dollar | superseded | [clm_D0295341E833](/claim/clm_D0295341E833.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | 1,440,951,000 United States dollar | superseded | [clm_D65EAAF57A7F](/claim/clm_D65EAAF57A7F.md)
- 2022-06-30 to 2022-09-30 | total_assets | 46,350,935,000 United States dollar | superseded | [clm_E49A1E31786F](/claim/clm_E49A1E31786F.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 5,819,449,000 United States dollar | superseded | [clm_F9D9C6D3667A](/claim/clm_F9D9C6D3667A.md)
- 2022-06-30 to 2022-09-30 | shares_outstanding | 444,705,591 shares | superseded | [clm_FB6F6BB9FC18](/claim/clm_FB6F6BB9FC18.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 662,739,000 United States dollar | superseded | [clm_24500C0A4947](/claim/clm_24500C0A4947.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 6,113,733,000 United States dollar | superseded | [clm_381FF31D39C3](/claim/clm_381FF31D39C3.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | 1,533,018,000 United States dollar | superseded | [clm_55E58D4C8BC2](/claim/clm_55E58D4C8BC2.md)
- 2022-09-30 to 2022-12-31 | total_assets | 47,562,187,000 United States dollar | superseded | [clm_9983A1EC971C](/claim/clm_9983A1EC971C.md)
- 2022-09-30 to 2022-12-31 | shares_outstanding | 445,020,494 shares | superseded | [clm_B932A3C7E4AD](/claim/clm_B932A3C7E4AD.md)
- 2022-09-30 to 2022-12-31 | total_equity | 20,528,141,000 United States dollar | superseded | [clm_C042654EC3D3](/claim/clm_C042654EC3D3.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 7,925,589,000 United States dollar | superseded | [clm_DA886460668F](/claim/clm_DA886460668F.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | 1,398,242,000 United States dollar | superseded | [clm_E5BE75F9EAD2](/claim/clm_E5BE75F9EAD2.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 2,711,041,000 United States dollar | superseded | [clm_16066F5DF82F](/claim/clm_16066F5DF82F.md)
- 2022-12-31 to 2023-12-31 | net_income | 4,491,924,000 United States dollar | superseded | [clm_19F2A6D6064A](/claim/clm_19F2A6D6064A.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 5,147,176,000 United States dollar | superseded | [clm_4678E0B77D37](/claim/clm_4678E0B77D37.md)
- 2022-12-31 to 2023-12-31 | revenue | 31,615,550,000 United States dollar | superseded | [clm_49369521CBB8](/claim/clm_49369521CBB8.md)
- 2022-12-31 to 2023-12-31 | operating_income | 5,632,831,000 United States dollar | superseded | [clm_8A827F62184E](/claim/clm_8A827F62184E.md)
- 2022-12-31 to 2023-03-31 | shares_outstanding | 445,346,776 shares | superseded | [clm_BED77DD700AB](/claim/clm_BED77DD700AB.md)
- 2022-12-31 to 2023-03-31 | total_assets | 48,594,768,000 United States dollar | superseded | [clm_E514F6A64D3C](/claim/clm_E514F6A64D3C.md)
- 2022-12-31 to 2023-03-31 | total_equity | 20,777,401,000 United States dollar | superseded | [clm_F601A6FB5244](/claim/clm_F601A6FB5244.md)

## 2023

- 2023-03-31 to 2023-06-30 | quarterly_operating_income | 1,714,317,000 United States dollar | superseded | [clm_1639FFD3B651](/claim/clm_1639FFD3B651.md)
- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 687,275,000 United States dollar | superseded | [clm_2E6B0748A6D9](/claim/clm_2E6B0748A6D9.md)
- 2023-03-31 to 2023-06-30 | shares_outstanding | 444,536,878 shares | superseded | [clm_4FFFAF5BAB5C](/claim/clm_4FFFAF5BAB5C.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 6,714,594,000 United States dollar | superseded | [clm_605D7E14CF17](/claim/clm_605D7E14CF17.md)
- 2023-03-31 to 2023-06-30 | total_equity | 21,828,196,000 United States dollar | superseded | [clm_8094214AB4BE](/claim/clm_8094214AB4BE.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | 1,305,120,000 United States dollar | superseded | [clm_CCCB9051B3EB](/claim/clm_CCCB9051B3EB.md)
- 2023-03-31 to 2023-06-30 | total_assets | 49,490,345,000 United States dollar | superseded | [clm_CEA9C3CE25C9](/claim/clm_CEA9C3CE25C9.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 8,161,503,000 United States dollar | superseded | [clm_CFC7681AA2B1](/claim/clm_CFC7681AA2B1.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 657,983,000 United States dollar | superseded | [clm_0E1618CDCCFB](/claim/clm_0E1618CDCCFB.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | 1,827,183,000 United States dollar | superseded | [clm_3253F46B8195](/claim/clm_3253F46B8195.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 7,662,788,000 United States dollar | superseded | [clm_6B8CB418E0EE](/claim/clm_6B8CB418E0EE.md)
- 2023-06-30 to 2023-09-30 | total_assets | 50,817,473,000 United States dollar | superseded | [clm_71E2D2871B0A](/claim/clm_71E2D2871B0A.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 1,487,610,000 United States dollar | superseded | [clm_AB9E64425F92](/claim/clm_AB9E64425F92.md)
- 2023-06-30 to 2023-09-30 | shares_outstanding | 443,146,751 shares | superseded | [clm_AC2EA00C76BA](/claim/clm_AC2EA00C76BA.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 8,187,301,000 United States dollar | superseded | [clm_B1C5F3D77BFB](/claim/clm_B1C5F3D77BFB.md)
- 2023-06-30 to 2023-09-30 | total_equity | 22,832,215,000 United States dollar | superseded | [clm_EF4A20E6C0DE](/claim/clm_EF4A20E6C0DE.md)
- 2023-09-06 | board_member | Susan Rice | valid | [clm_C03A741B7467](/claim/clm_C03A741B7467.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | 1,916,394,000 United States dollar | superseded | [clm_06703955511F](/claim/clm_06703955511F.md)
- 2023-09-30 to 2023-12-31 | shares_outstanding | 437,679,669 shares | superseded | [clm_0D8D2977B830](/claim/clm_0D8D2977B830.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | 1,677,422,000 United States dollar | superseded | [clm_3866C3450269](/claim/clm_3866C3450269.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 657,159,000 United States dollar | superseded | [clm_9E472C341058](/claim/clm_9E472C341058.md)
- 2023-09-30 to 2023-12-31 | total_assets | 49,501,786,000 United States dollar | superseded | [clm_AEB668BB0FCC](/claim/clm_AEB668BB0FCC.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 7,353,245,000 United States dollar | superseded | [clm_B62433BD6618](/claim/clm_B62433BD6618.md)
- 2023-09-30 to 2023-12-31 | total_equity | 22,107,627,000 United States dollar | superseded | [clm_C8464926EBD0](/claim/clm_C8464926EBD0.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 8,541,668,000 United States dollar | superseded | [clm_CEC3616CC29A](/claim/clm_CEC3616CC29A.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 7,116,913,000 United States dollar | superseded | [clm_5F4CF9ED200E](/claim/clm_5F4CF9ED200E.md)
- 2023-12-31 to 2024-12-31 | net_income | 5,407,990,000 United States dollar | superseded | [clm_761D0CABDB8F](/claim/clm_761D0CABDB8F.md)
- 2023-12-31 to 2024-03-31 | total_equity | 20,588,313,000 United States dollar | superseded | [clm_774F7F991333](/claim/clm_774F7F991333.md)
- 2023-12-31 to 2024-03-31 | total_assets | 48,731,992,000 United States dollar | superseded | [clm_795D0545B7B2](/claim/clm_795D0545B7B2.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 2,675,758,000 United States dollar | superseded | [clm_84C8CB6AA3CF](/claim/clm_84C8CB6AA3CF.md)
- 2023-12-31 to 2024-12-31 | revenue | 33,723,297,000 United States dollar | superseded | [clm_8C6AF95107E5](/claim/clm_8C6AF95107E5.md)
- 2023-12-31 to 2024-03-31 | shares_outstanding | 432,759,584 shares | superseded | [clm_AE6BE2B0F02F](/claim/clm_AE6BE2B0F02F.md)
- 2023-12-31 to 2024-12-31 | operating_income | 6,954,003,000 United States dollar | superseded | [clm_ED44AFBC8F28](/claim/clm_ED44AFBC8F28.md)

## 2024

- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 7,024,766,000 United States dollar | superseded | [clm_32F67000F5C7](/claim/clm_32F67000F5C7.md)
- 2024-03-31 to 2024-06-30 | total_assets | 48,827,721,000 United States dollar | superseded | [clm_3D4DE936B087](/claim/clm_3D4DE936B087.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 9,370,440,000 United States dollar | superseded | [clm_5104AE3809DD](/claim/clm_5104AE3809DD.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 2,332,209,000 United States dollar | superseded | [clm_531986256BEA](/claim/clm_531986256BEA.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | 2,632,534,000 United States dollar | superseded | [clm_8214160683F8](/claim/clm_8214160683F8.md)
- 2024-03-31 to 2024-06-30 | shares_outstanding | 430,964,991 shares | superseded | [clm_BB8EC3BC742D](/claim/clm_BB8EC3BC742D.md)
- 2024-03-31 to 2024-06-30 | total_equity | 21,365,410,000 United States dollar | superseded | [clm_D09044EA78EE](/claim/clm_D09044EA78EE.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 702,473,000 United States dollar | superseded | [clm_E28F19FE2893](/claim/clm_E28F19FE2893.md)
- 2024-06-30 to 2024-09-30 | total_equity | 22,112,693,000 United States dollar | superseded | [clm_1C55AD76C576](/claim/clm_1C55AD76C576.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 9,559,310,000 United States dollar | superseded | [clm_4D35D1C2FF84](/claim/clm_4D35D1C2FF84.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | 2,147,306,000 United States dollar | superseded | [clm_63BEBC543E83](/claim/clm_63BEBC543E83.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | 2,602,837,000 United States dollar | superseded | [clm_663E9F466988](/claim/clm_663E9F466988.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 6,624,939,000 United States dollar | superseded | [clm_A6D64242FB03](/claim/clm_A6D64242FB03.md)
- 2024-06-30 to 2024-09-30 | total_assets | 49,098,895,000 United States dollar | superseded | [clm_C0B256878134](/claim/clm_C0B256878134.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 711,254,000 United States dollar | superseded | [clm_DC7D67FE2107](/claim/clm_DC7D67FE2107.md)
- 2024-06-30 to 2024-09-30 | shares_outstanding | 429,164,615 shares | superseded | [clm_EB76ED2B4D04](/claim/clm_EB76ED2B4D04.md)
- 2024-09-30 to 2024-12-31 | total_equity | 22,720,736,000 United States dollar | superseded | [clm_02EA1AB31967](/claim/clm_02EA1AB31967.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 9,824,703,000 United States dollar | superseded | [clm_1117D10452E0](/claim/clm_1117D10452E0.md)
- 2024-09-30 to 2024-12-31 | total_assets | 52,281,844,000 United States dollar | superseded | [clm_43659AC60E34](/claim/clm_43659AC60E34.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 2,363,509,000 United States dollar | superseded | [clm_458964941E70](/claim/clm_458964941E70.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | 2,909,477,000 United States dollar | superseded | [clm_6EAD93913712](/claim/clm_6EAD93913712.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 735,063,000 United States dollar | superseded | [clm_7FF37B49BCD2](/claim/clm_7FF37B49BCD2.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 7,457,025,000 United States dollar | superseded | [clm_BC1A3505177D](/claim/clm_BC1A3505177D.md)
- 2024-09-30 to 2024-12-31 | shares_outstanding | 427,458,114 shares | superseded | [clm_F11F18161E8C](/claim/clm_F11F18161E8C.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 2,925,295,000 United States dollar | superseded | [clm_0ECEC6CB5FAB](/claim/clm_0ECEC6CB5FAB.md)
- 2024-12-31 to 2025-12-31 | net_income | 8,711,631,000 United States dollar | superseded | [clm_132BB6931F27](/claim/clm_132BB6931F27.md)
- 2024-12-31 to 2025-03-31 | total_assets | 53,630,374,000 United States dollar | superseded | [clm_1E6C4D73A3CE](/claim/clm_1E6C4D73A3CE.md)
- 2024-12-31 to 2025-03-31 | total_equity | 24,743,567,000 United States dollar | superseded | [clm_28AB70755F40](/claim/clm_28AB70755F40.md)
- 2024-12-31 to 2025-12-31 | operating_income | 10,417,614,000 United States dollar | superseded | [clm_2AF4F56FBF2A](/claim/clm_2AF4F56FBF2A.md)
- 2024-12-31 to 2025-12-31 | revenue | 39,000,966,000 United States dollar | superseded | [clm_2B731F354FFD](/claim/clm_2B731F354FFD.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 7,804,733,000 United States dollar | superseded | [clm_4DFC6AE66D1E](/claim/clm_4DFC6AE66D1E.md)
- 2024-12-31 to 2025-03-31 | shares_outstanding | 427,757,100 shares | superseded | [clm_AAB77BF6DCFF](/claim/clm_AAB77BF6DCFF.md)

## 2025

- 2025-03-31 to 2025-06-30 | quarterly_revenue | 10,542,801,000 United States dollar | superseded | [clm_50705492B0C1](/claim/clm_50705492B0C1.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | 3,346,999,000 United States dollar | superseded | [clm_6C7BAD939986](/claim/clm_6C7BAD939986.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 822,823,000 United States dollar | superseded | [clm_90819B8E17BF](/claim/clm_90819B8E17BF.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 7,199,848,000 United States dollar | superseded | [clm_ACE8FE4175DB](/claim/clm_ACE8FE4175DB.md)
- 2025-03-31 to 2025-06-30 | total_assets | 52,087,644,000 United States dollar | superseded | [clm_DB770EFB88A1](/claim/clm_DB770EFB88A1.md)
- 2025-03-31 to 2025-06-30 | shares_outstanding | 425,683,210 shares | superseded | [clm_DEDFBA774B31](/claim/clm_DEDFBA774B31.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | 2,890,351,000 United States dollar | superseded | [clm_F283F55244C6](/claim/clm_F283F55244C6.md)
- 2025-03-31 to 2025-06-30 | total_equity | 24,028,073,000 United States dollar | superseded | [clm_FA57083C0A6D](/claim/clm_FA57083C0A6D.md)
- 2025-04-17 | chair | Reed Hastings | valid | [clm_6EF3AF1672C1](/claim/clm_6EF3AF1672C1.md)
- 2025-06-22 | board_member | Elinor Mertz | valid | [clm_DCFF3F41DD2F](/claim/clm_DCFF3F41DD2F.md)
- 2025-06-30 to 2025-09-30 | total_equity | 24,951,899,000 United States dollar | superseded | [clm_0331AA361898](/claim/clm_0331AA361898.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 824,683,000 United States dollar | superseded | [clm_42A91D2DF1F1](/claim/clm_42A91D2DF1F1.md)
- 2025-06-30 to 2025-09-30 | shares_outstanding | 424,926,346 shares | superseded | [clm_564B3B3D63A1](/claim/clm_564B3B3D63A1.md)
- 2025-06-30 to 2025-09-30 | total_assets | 53,099,664,000 United States dollar | superseded | [clm_661F8541D2E7](/claim/clm_661F8541D2E7.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | 3,774,694,000 United States dollar | superseded | [clm_A6E2FE7A87F1](/claim/clm_A6E2FE7A87F1.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 8,177,405,000 United States dollar | superseded | [clm_C83DCE023842](/claim/clm_C83DCE023842.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | 3,125,413,000 United States dollar | superseded | [clm_D0D02FC52F9B](/claim/clm_D0D02FC52F9B.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 11,079,166,000 United States dollar | superseded | [clm_E7D41CE418AE](/claim/clm_E7D41CE418AE.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 11,510,307,000 United States dollar | superseded | [clm_39236389AB02](/claim/clm_39236389AB02.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | 3,248,247,000 United States dollar | superseded | [clm_85C5921D3DE4](/claim/clm_85C5921D3DE4.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 2,546,916,000 United States dollar | superseded | [clm_87831FADE65A](/claim/clm_87831FADE65A.md)
- 2025-09-30 to 2025-12-31 | shares_outstanding | 423,732,334 shares | superseded | [clm_A5D363C4558C](/claim/clm_A5D363C4558C.md)
- 2025-09-30 to 2025-12-31 | total_equity | 25,954,035,000 United States dollar | superseded | [clm_B964F14FC2CD](/claim/clm_B964F14FC2CD.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 853,584,000 United States dollar | superseded | [clm_CEA9B992329F](/claim/clm_CEA9B992329F.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 9,287,287,000 United States dollar | superseded | [clm_D660C9A43CA4](/claim/clm_D660C9A43CA4.md)
- 2025-09-30 to 2025-12-31 | total_assets | 54,934,835,000 United States dollar | superseded | [clm_D9C74F52AF5C](/claim/clm_D9C74F52AF5C.md)
- 2025-12-04 | agreement | Warner Bros. Discovery, Inc. | valid | [clm_BA96F3B48B72](/claim/clm_BA96F3B48B72.md)
- 2025-12-31 to 2026-03-31 | total_assets | 55,596,993,000 United States dollar | superseded | [clm_022B30099DB2](/claim/clm_022B30099DB2.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 9,033,681,000 United States dollar | superseded | [clm_07D84B0634F8](/claim/clm_07D84B0634F8.md)
- 2025-12-31 | operating_income | 13,326,603,000 United States dollar | valid | [clm_46D6F7E14264](/claim/clm_46D6F7E14264.md)
- 2025-12-31 | revenue | 45,183,036,000 United States dollar | valid | [clm_4EA8935894A5](/claim/clm_4EA8935894A5.md)
- 2025-12-31 to 2026-03-31 | total_equity | 26,615,488,000 United States dollar | superseded | [clm_AD9A40A0F80B](/claim/clm_AD9A40A0F80B.md)
- 2025-12-31 | net_income | 10,981,201,000 United States dollar | valid | [clm_CC64236741BB](/claim/clm_CC64236741BB.md)
- 2025-12-31 to 2026-03-31 | shares_outstanding | 4,222,162,150 shares | superseded | [clm_EB57EB4762C2](/claim/clm_EB57EB4762C2.md)
- 2025-12-31 | research_and_development | 3,391,390,000 United States dollar | valid | [clm_EF2851038FF0](/claim/clm_EF2851038FF0.md)

## 2026

- 2026-03-31 to 2026-06-30 | quarterly_net_income | 5,282,791,000 United States dollar | superseded | [clm_0AC262E28CAB](/claim/clm_0AC262E28CAB.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 3,956,997,000 United States dollar | superseded | [clm_3886D392A3F3](/claim/clm_3886D392A3F3.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 12,249,757,000 United States dollar | superseded | [clm_39A001BFA7A4](/claim/clm_39A001BFA7A4.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 959,696,000 United States dollar | superseded | [clm_590D21BBC411](/claim/clm_590D21BBC411.md)
- 2026-03-31 to 2026-06-30 | total_assets | 61,015,914,000 United States dollar | superseded | [clm_75CD677D2D68](/claim/clm_75CD677D2D68.md)
- 2026-03-31 to 2026-06-30 | total_equity | 31,126,399,000 United States dollar | superseded | [clm_9A2BE1301AD5](/claim/clm_9A2BE1301AD5.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 12,259,772,000 United States dollar | superseded | [clm_C486C4668799](/claim/clm_C486C4668799.md)
- 2026-03-31 to 2026-06-30 | shares_outstanding | 4,212,794,271 shares | superseded | [clm_D7A7BB3D1537](/claim/clm_D7A7BB3D1537.md)
- 2026-06-30 to 2026-09-30 | total_equity | 30,152,052,000 United States dollar | superseded | [clm_0D26EA9B4B4F](/claim/clm_0D26EA9B4B4F.md)
- 2026-06-30 to 2026-09-30 | quarterly_net_income | 3,401,414,000 United States dollar | superseded | [clm_5B0C7C3E8FD6](/claim/clm_5B0C7C3E8FD6.md)
- 2026-06-30 to 2026-09-30 | cash_and_equivalents | 9,099,232,000 United States dollar | superseded | [clm_8097BCD4413F](/claim/clm_8097BCD4413F.md)
- 2026-06-30 to 2026-09-30 | quarterly_research_and_development | 1,007,675,000 United States dollar | superseded | [clm_84B827978A89](/claim/clm_84B827978A89.md)
- 2026-06-30 to 2026-09-30 | shares_outstanding | 4,163,939,676 shares | superseded | [clm_89454B7C3C58](/claim/clm_89454B7C3C58.md)
- 2026-06-30 to 2026-09-30 | quarterly_revenue | 12,559,938,000 United States dollar | superseded | [clm_B14998A541B3](/claim/clm_B14998A541B3.md)
- 2026-06-30 to 2026-09-30 | quarterly_operating_income | 4,192,610,000 United States dollar | superseded | [clm_BEFB39A25931](/claim/clm_BEFB39A25931.md)
- 2026-06-30 to 2026-09-30 | total_assets | 58,450,441,000 United States dollar | superseded | [clm_F60C1256545D](/claim/clm_F60C1256545D.md)
- 2026-09-30 | total_equity | 29,286,253,000 United States dollar | valid | [clm_14596A6DEAE5](/claim/clm_14596A6DEAE5.md)
- 2026-09-30 | shares_outstanding | 4,106,325,903 shares | valid | [clm_2F8E36FEDFE3](/claim/clm_2F8E36FEDFE3.md)
- 2026-09-30 | quarterly_revenue | 12,874,176,000 United States dollar | valid | [clm_3D9073C1FE6D](/claim/clm_3D9073C1FE6D.md)
- 2026-09-30 | quarterly_research_and_development | 1,033,142,000 United States dollar | valid | [clm_71333A68E883](/claim/clm_71333A68E883.md)
- 2026-09-30 | quarterly_operating_income | 4,458,600,000 United States dollar | valid | [clm_B399DC77E516](/claim/clm_B399DC77E516.md)
- 2026-09-30 | total_assets | 58,681,954,000 United States dollar | valid | [clm_CF279B137464](/claim/clm_CF279B137464.md)
- 2026-09-30 | cash_and_equivalents | 8,194,275,000 United States dollar | valid | [clm_DE431095BF4A](/claim/clm_DE431095BF4A.md)
- 2026-09-30 | quarterly_net_income | 3,663,927,000 United States dollar | valid | [clm_DFFDE1DCC68E](/claim/clm_DFFDE1DCC68E.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.